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SUMMARY 
 
Lipids are essential constituants for living organisms. They play various roles as energetic 
molecules, chemical messengers, membrane constituants and hormones. Several cascades of 
enzymatic reactions allow the conversion of glucose to acetyl-CoA, a substrate of the fatty acid 
synthase and the diversification of fatty acid to triacylglycerol, glycerophospholipids, 
sphingolipids and saccharolipids.   
The first part of the thesis focuses on a homologue of the fatty acid synthase, which 
possesses the same structure and catalyses similar chemical reaction: the polyketide synthase 
(PKS). Polyketide are predominantly from microbial and plants origin. They are structurally 
complex compounds compared to the linear hydrocarbon chain of fatty acid. These molecules 
are interesting for their anti-microbial, anti-parasitic and anti-cancer properties. Understanding 
the synthesis mechanism of PKS is of main interest for the discovery of new therapeutical 
molecules. The family of trans-acyltransferase (AT) PKS are particularly attractive as they use an 
external AT for loading the acetyl-CoA to the PKS. This AT, which is not integrated into the 
assembly line of the PKS, may be easily switched to another AT. Incorporation of non-natural 
substrates to the polyketide backbone may generate new biologically active polyketides. The 
research project presented in this thesis investigates the mechanism of substrate delivery from 
the external AT to the trans-AT PKS. In canonical (called cis-AT) PKS, AT is attached by a rigid 
linker domain to the ketosynthase (KS) domain responsible for the chain elongation reaction. 
Here, the crystal structure of the ketosynthase domain from a Brevibacillus brevis (B.brevis) 
trans-AT PKS shows the conservation of the linker domain with a potential docking interface at 
the corresponding position of the AT in cis-AT PKS. From structure analysis and sequence 
alignment of 236 C-terminal linkers of KS domain from trans-AT PKS, four classes of docking 
interface were identified. The docking interface of the B. brevis KS-LD belonging to the class I 
presents a central hydrophobic groove and surrounding charge residues which form contact with 
neighbouring KS-LD in the crystal structure suggesting that this docking interface could be 
potentially used by a trans-AT. The structural organization of the trans-AT protein was further 
investigated in collaboration with the Dr. Roman Jakob. The trans-AT can be coupled to an enoyl-
reductase (ER) in certain trans-AT PKS. The crystal structure of a trans-ER and the small-angle X-
ray scattering (SAXS) analysis of a trans-AT-ER reveal the dimerization of the trans-AT-ER protein 
at the ER interface. From those results, a model of the organization of the trans-AT PKS could be 
suggested. In the trans-AT-ER proteins, the ER dimerizes and the AT may bind to linker domain of 
the KS.  
The second part focuses on another protein of lipid synthesis cascade. The lipin catalyses 
the penultimate step of triacylglycerol synthesis by dephosphorylating the phosphatidate into 
diacylglycerol. The lipin is also transcription coactivator of lipid metabolism regulating genes. 
Role of lipin in the development of fatty liver dystrophy in mice has been shown and there are 
growing evidences that mutations and polymorphisms are responsible for metabolic and 
inflammatory disorders in human. The X-ray crystallographic and biochemical studies are of main 
interest to explore the effect of mutations on the lipin function and structure. Here, the 
bioinformatics analysis of lipin from several organisms helps mapping the structurally conserved 
 
 
 
 
4
and highly disordered regions and allows the selection of lipin candidate susceptible to 
crystallise. This thesis reports a protocol optimized for the expression and purification of the 
Kluyveromyces lactis lipin homologue PAH1 construct (Klarg, Met1 to Arg527). Initial biochemical 
studies reveal the monomeric and oligomeric states of Klarg. These states are not in equilibrium, 
independent of phosphorylation and, for the oligomeric form, resistant to reducing conditions. 
Activity assay and crystallisation test have been started but they require further optimization.  
 
 
 
 
  
 
 
 
 
5
TABLE OF CONTENTS 
SUMMARY 3 
LIST OF FIGURES 6 
LIST OF TABLES 8 
LIST OF ABBREVIATIONS 9 
INTRODUCTION 11 
BIOASSEMBLY OF STORAGE LIPIDS 11 
PART I: STRUCTURAL ORGANIZATION OF TRANS-AT POLYKETIDE SYNTHASE 14 
TYPE I POLYKETIDE SYNTHASE 14 
SIMILARITIES BETWEEN MFAS AND TYPE I PKS 15 
ENGINEERING TYPE I PKS TO PRODUCE NEW BIOLOGICALLY ACTIVE POLYKETIDE 17 
TRANS-AT PKS, AN ATTRACTIVE ALTERNATIVE FOR PKS ENGINEERING 18 
AIM OF RESEARCH: INSIGHT INTO THE MECHANISM OF SUBSTRATE DELIVERY OF TRANS-AT PKS 19 
PART II: LIPIN, A KEY REGULATOR IN LIPID METABOLISM 20 
THE LIPIN FAMILY 20 
LIPIN, A PHOSPHATIDATE PHOSPHATASE 22 
LIPIN, A TRANSCRIPTIONAL COACTIVATOR 24 
REGULATION AND SUBCELLULAR LOCALIZATION OF LIPINS 24 
LIPIN MUTATIONS, POLYMORPHISMS AND ASSOCIATED DISEASES 26 
AIM OF THE RESEARCH WORK 26 
PART I     THE STRUCTURAL ORGANIZATION OF TRANS-AT POLYKETIDE SYNTHASES: KETOACYL 
SYNTHASE AND TRANS-ACTING ENOYL REDUCTASE 29 
STATEMENT OF MY OWN CONTRIBUTION 30 
SUPPLEMENTARY INFORMATION 48 
PART II    EXPRESSION, PURIFICATION AND BIOPHYSICAL CHARACTERIZATION OF LIPIN, A KEY 
REGULATOR OF LIPID METABOLISM 79 
STATEMENT OF MY OWN CONTRIBUTION 80 
SUPPLEMENTARY INFORMATION 97 
CONCLUSION & OUTLOOK 108 
ACKNOWLEGMENTS 111 
REFERENCES 112 
  
 
 
 
 
6
LIST OF FIGURES 
 
Figure 1: Lipid biosynthesis (adapted from Baenke, et al. 2006 [6]). _______________________ 12 
Figure 2:  Chemical structure of the fatty acid Palmitic acid, a common product of the FAS, and 
the polyketide 6-Deoxyerythronolide, synthesized by PKS from Saccharopolyspora erythreae and 
precursor of the Erythromycine antibiotic [8]. ________________________________________ 13 
Figure 3: Structures, origins and biological activities of natural polyketides. ________________ 14 
Figure 4: Domain organization and mechanism of bacterial PKS (adapted from Shen 2003 [12]). 15 
Figure 5: Main characteristics of the mFAS and the standard type I PKS. ___________________ 16 
Figure 6: Structure of the crystallized dimeric KS-LD-AT domain from mFAS and DEBS module 3.17 
Figure 7: Schematic view of the cis-AT PKS DEBS and the hybrid NRPS/trans-AT PKS PKS C0ZGQ5 
from B. brevis. _________________________________________________________________ 19 
Figure 8: Simplified scheme of the role of lipins in the de novo phospholipid biosynthetic 
pathways. ____________________________________________________________________ 20 
Figure 9 : Mapping of the functional domains on Lipin 1 and ScPAH1. _____________________ 21 
Figure 10: Mouse lipin expression profile (adapted from (Csaki et al., 2013)). _______________ 22 
Figure 11: Scheme of the role, regulation and cellular localization of lipin 1. ________________ 23 
Figure 12: Schematic view of the domain organization of the DEBS cis-AT PKS and the B. brevis 
trans-AT PKS. __________________________________________________________________ 34 
Figure 13: Overall structure of the dimeric B. brevis KS2 and comparison to other PKS 
ketosynthases. ________________________________________________________________ 35 
Figure 14: Comparison of the extensions of the core fold of Bb-KS2 with PKS, FAS and KAS II. __ 36 
Figure 15: Comparison of the linker domain from trans and cis-AT PKS. ___________________ 37 
Figure 16: Overall structure of MlnA-ER and comparison to other enoyl reductases. _________ 39 
Figure 17: In solution small-angle X-ray scattering analysis of ATx-ER proteins. ______________ 42 
Figure 18: Model of cis- and trans-AT PKS organization. ________________________________ 44 
Figure 19: Characteristics of the mammalian lipin, Dm lipin and fungal PAH1 observed by 
sequence alignment and secondary structure prediction. ______________________________ 84 
Figure 20: Characteristics of the fungal PAH1 identified by sequence alignment of 75 PAH1 
obtained from pBlast with ScPAH1. ________________________________________________ 87 
Figure 21: Last purification step of HMF-Klarg and untagged-Klarg on Superdex 200 16/600. __ 90 
Figure 22: Determination of the oligomeric state of Klarg by SEC-MALS. ___________________ 91 
 
 
Figure S 1: Schematic view of the hybrid NRPS/PKS cluster from Brevibacillus brevis. ________ 62 
Figure S 2: Comparison of core-fold extensions in thiolase fold-like enzymes. _______________ 63 
Figure S 3: Active site and substrate binding pocket of Bb-KS2. __________________________ 64 
Figure S 4: Dimer interface of Bb-KS2. ______________________________________________ 65 
Figure S 5: Interface of KS with the downstream domain. _______________________________ 66 
Figure S 6: Multiple sequence alignment of the short α-helical extension (aa. 2571-2577) from Bb-
KS2 with KS from trans-AT PKS. ___________________________________________________ 67 
Figure S 7: Multiple sequence alignment of the β-sheet extension (aa. 2725-2737) from Bb-KS2 
with several trans-AT PKS. _______________________________________________________ 68 
 
 
 
 
7
Figure S 8: Sequence alignment of the linker domain from trans-AT PKS. __________________ 69 
Figure S 9: Crystal contacts at the docking domain of Bb-KS2 linker. ______________________ 70 
Figure S 10: Schematic view of the macrolactin cluster from B. amyloliquefaciens FZB42. _____ 71 
Figure S 11: Dimer Interface of MlnA. ______________________________________________ 72 
Figure S 12: Active site of MlnA. ___________________________________________________ 73 
Figure S 13: Multiple sequence alignment of the AT-ER proteins from several species. _______ 74 
Figure S 14: Multiple sequence alignment of the ER proteins from trans-AT and PUFA biosynthesis 
pathways. ____________________________________________________________________ 75 
Figure S 15: Multiple sequence alignment of the AT-to-ER linker from several species. _______ 76 
Figure S 16: Molecular weight determination using size-exclusion chromatography coupled to 
multi-angle light scattering (SEC-MALS). ____________________________________________ 77 
Figure S 17: Distance distribution (A, C) and Kratky analysis (B, D) of AT-AT and AT-ER didomain 
proteins. _____________________________________________________________________ 78 
Figure S 18: Sequence alignment of hLPIN1, 2, 3 , mLPIN1, 2, 3, DmLPIN, KlPAH1, ScPAH1, 
CtPAH1. _____________________________________________________________________ 100 
Figure S 19 : Sequence alignment of 75 sequences of fungal PAH1. ______________________ 101 
Figure S 20: C-terminal tail of 75 fungal PAH1. ______________________________________ 102 
Figure S 21: Limited proteolysis of the full-length KlPAH1. _____________________________ 103 
Figure S 22: Elution of the small variant of KlPAH1 (Klarg, Met1-Arg 527) from Ni-NTA 
chromatography column. _______________________________________________________ 104 
Figure S 23: Gel filtration of HMF-ScPAH1 and untagged-ScPAH1 on Superdex 200 16/600. __ 105 
Figure S 24: Melting temperature of Klarg and ScPAH1 measure by thermofluorassay. ______ 106 
Figure S 25: Sequence alignment and mapping of phosphosite on ScPAH1 and KlPAH1. ______ 107 
 
  
 
 
 
 
8
LIST OF TABLES 
 
Table 1: Melting temperatures of Klarg and ScPAH1 depending on buffer, pH and salt conditions.
 _____________________________________________________________________________ 92 
 
 
Table S 1: Data collection and refinement statistics of Bb-KS2-LD and MlnA-ER. _____________ 49 
Table S 2: Classification of the KS domain according to the precursor specificity and the residues 
localized within 15Å around the reactive cysteine [136]. _______________________________ 50 
Table S 3: Classification and characteristics of ketosynthase from trans-AT PKS. _____________ 51 
Table S 4: Trans-AT PKS sequences used for sequence alignment shown on the figures S6, S7, S8 
and S9. _______________________________________________________________________ 60 
Table S 5: Data collection and scattering-derived parameters for AT1AT2 (C0ZGR0) and AT-ER 
(DfnA). _______________________________________________________________________ 61 
Table S 6: Sequence similarity between lipins based on sequence alignment. _______________ 98 
Table S 7: Expression of recombinant lipin in E. coli. ___________________________________ 99 
 
  
 
 
 
 
9
LIST OF ABBREVIATIONS 
 
A Adenylation domain 
aa Amino acid 
ACC Acetyl-Coa carboxylase  
ACP Acyl carrier protein  
AFLD Alcoholic fatty liver disease 
AT Acyltransferase 
AUC Analytical ultracentrifugation  
B. brevis Brevibacillus brevis  
Bb Brevibacillus brevis  
C Condensation domain 
C16 16-carbon fatty acid 
C20 20-carbon fatty acid 
CoA Coenzyme A  
Ct Chaetomium thermophilum 
CTDNEP1 C-terminal domain nuclear envelope phosphatase 1 
DAG Diacylglycerol 
DEBS 6-deoxyerythronolide b synthase  
DH Dehydratase 
Dm Drosophila melanogaster  
E. coli Escherichia coli  
EM Electronic microscopy 
ER Enoyl reductase  
ER membrane Endoplasmic reticulum membrane 
FA Fatty acid 
FAS Fatty acid Synthase  
fld Fatty liver dystrophy  
FMN Flavin mononucleotide  
GF Gel filtration 
HAL HIV-associated lipodystrophy 
HMF N-term-10His-Myc-Flag-TEV tag 
KASI Β-ketoacyl-(acyl-carrier-protein) synthase I 
Kl Kluyveromyces lactis  
KR Ketoreductase 
KS Ketosynthase 
LD Linker domain  
MAT Malonyl- acetyl transferase 
MEF2 Myocyte enhancer factor 2  
mFAS Mammalian fatty acid synthase  
MGM Malachite green molybdate 
MST Microscale thermophoresis  
mTORC Mammalian target of rapamycin complex 
NEP1-R1 Nuclear envelope phosphatase 1-regulatory subunit 1  
NFATc4 Nuclear factor of activated T-cells c4 
NLS Nuclear localization signal 
NMR Nuclear magnetic resonnance 
 
 
 
 
10 
NRPS Non-ribosomal peptides synthetase  
PA Phosphatidate 
PAP Phosphatidate phosphatase  
PBD Polybasic domain  
PC Phosphatidylcholine 
PE Phosphatidylethanolamine 
PGC-1 α PPARγ  coactivator 1 α   
PI Phosphoinositide 
PKS Polyketide synthase  
PP-1cγ Ser/Thr protein phosphatase 1 catalytic unit γ  
PPARγ Peroxisome proliferator-activated receptor γ  
PPARα Peroxisome proliferator-activated receptor α   
PS Phosphatidylserine 
PUFAs Polyunsaturated fatty acids  
rmsd Root-mean-square deviation  
SAXS Small-angle X-ray scattering  
Sc Saccharomyces cerevisiae 
SCD Stearoyl-Coa desaturase 
SEC-MALS  Size-exclusion chromatography coupled to multi angle light scattering  
SPR Surface plasmon resonance  
SRD Serine rich domain  
SREBP1 Sterol response element binding protein 1 
TAD Transcriptional activation domain  
TAG Triacylglycerol 
TE Thioesterase 
 
 
 
 
 
 
11 
INTRODUCTION 
Bioassembly Of Storage Lipids 
Lipids are essential for life as they provide substrates for energy metabolism, membrane 
synthesis, and play a critical role as secondary messengers in cellular signaling pathways [1]. 
Excess of free fatty acids (FA) can lead to cell dysfunction [2]. Disorders in TAG synthesis and 
storage occur in obesity and lipodystrophy and increase susceptibility to cardiovascular disease, 
diabetes mellitus, and dyslipidemia [1]. Therefore lipid storage in the form of neutral 
triacylglycerol (TAG) in lipid droplets is essential [2, 3]. 
Lipids are synthesized from the conversion of nutrient-derived carbons through a cascade 
of enzymatic reactions. Glucose or glutamine-derived citrate is converted to acetyl-bound 
Coenzyme A (acetyl-CoA), the first building block of FA (Figure 1). The acetyl-CoA carboxylase 
(ACC) converts the acetyl-CoA into malonyl-CoA, the second building block of FA. The repeated 
condensation of acetyl-CoA and malonyl-CoA by the multifunctional enzyme Fatty acid Synthase 
(FAS) leads to the generation of palmitic acid, a fully saturated 16-carbon (C16) FA. Palmitic acid 
can be further elongated and desaturated to generate a diverse spectrum of saturated antransd 
unsaturated FA. For example, the stearoyl-CoA desaturase (SCD) introduces a double bond at the 
9th position from the carboxyl end of palmitic and stearic acid to generate monounsaturated FA. 
Interestingly, humans are not able to generate FA that are unsaturated at the 3rd and 6th 
position from the end of the carbon chain of the acyl chain. These FA named α-linolenic acid and 
linoleic acid are called “essential FA” and must be obtained from the diet.  
FA are used to generate many different types of lipids of critical cellular function. 
Condensation of palmitic acid with serine followed by enzymatic reduction forms 
dihydrosphingosine, a precursor of the sphingolipids family. [4]. Besides playing structural roles 
in cellular membranes, sphingolipids such as ceramide, sphingosine, and sphingosine-1-
phosphate, are bioactive signaling molecules involved in the regulation of cell growth, 
differentiation, senescence and apoptosis. The arachidonic acid (C20) is a precursor of 
eicosanoids such as prostaglandin, thromboxanes and leukotriene. Eicosanoids play an important 
role in inflammation by regulating vasodilatation, vascular permeability, pain and leukocytes 
recruitement [5].  
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Figure 1: Lipid biosynthesis (adapted from Baenke, et al. 2006 [6]).  Enzymes of the lipid biosynthetic pathways are 
indicated in green. (a) Glucose- or glutamine-derived citrate is first converted to acetyl-CoA by ACLY. (b) For FA 
biosynthesis, acetyl-CoA is converted into malonyl-CoA. The repeated condensation of acetyl-CoA and malonyl-CoA by 
the multifunctional enzyme FAS leads to the generation of palmitic acid, a fully saturated 16-carbon FA. The introduction 
of a double bond in the Δ9 position of the acyl chain by SCD generates mono-unsaturated FAs. (c) Subsequent elongation 
and further desaturation produces the repertoire of FAs with different saturation levels. (d) Essential FAs (ω3 and ω6 FAs) 
cannot be synthesised by human cells and need to be provided from dietary sources. (e,f) Saturated and unsaturated FAs 
are combined with glycerol-3-phosphate (glycerol-3-P) to generate (e) phosphoglycerides and (f) phosphoinositides. (g) 
Arachidonic acid, a long-chain polyunsaturated FA, is used for the synthesis of eicosanoids. (h) Sphingolipids contain acyl 
chains and polar head groups derived from serine, phosphocholine or phosphoethanolamine. Enzyme abbreviations: 
ACAT, acetyl-CoA acetyltransferase; ACC, acetyl-CoA carboxylase; ACLY, ATP citrate lyase; AGPAT, 1-acylglycerol-3-
phosphate O- acyltransferase; COX1/2, prostaglandin-endoperoxide synthase (PTGS); DGAT, diacylglycerol O-
acyltransferase; ELOVL, fatty acid elongase; FADS, fatty acid desaturase; FAS, fatty acid synthase; GPAT, glycerol-3-
phosphate acyltransferase; PAP, phosphatidic acid phosphatase; SCD, stearoyl-CoA desaturase; SPHK, sphingosine-1-
kinase. Metabolite abbreviations: α-KG, α-ketoglutarate; CDP-DAG, cytidine diphosphate-diacylglycerol; CER, ceramide; 
DAG, diacylglycerol; FA, fatty acid; LPA, lysophosphatidic acid; PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PG, phosphatidylglycerol; PGE2, prostaglandin E2; PGH2, prostaglandin H2; PI, 
phosphatidylinositol; PIP, phosphatidylinositol phosphate; PS, phosphatidylserine; S1P, sphingosine-1-phosphate; SPH, 
sphingosine; TAG, triacylglyceride. TCA: tricarboxylic acid cycle.  
 
FA are also incorporated into the phosphoglyceride pathway, which produces on one hand 
the TAG for FA storage in lipid droplets and on the other hand phosphoglycerides and 
phosphoinositides. In this pathway, two FA are sequentially coupled to glycerol-3-Phosphate to 
form phosphatidate. Phosphatidate (PA) can be dephosphorylated by a phosphatidate 
phosphatase to diacylglycerol. Diacylglycerol is then used for the synthesis of major structural 
components of biological membranes like phosphatidylcholine (PC), phosphatidylethanolamine 
(PE) and phosphatidylserine (PS) or is further coupled to one FA chain to generate TAG. The 
branch of the phosphoglyceride pathway converts PA to PS, PE, PC or to phosphoinositide (PI). PI, 
like phosphatidylinositol (3,4,5)-trisphosphate, is highly specific binding platform for recruitment 
of effector protein to specific membrane compartment.  
Considering such a large panel of activities, it is important that excessive FA are stored 
into TAG pool to protect against lipotoxicity. This thesis focuses on two effectors of the lipid 
synthesis and storage pathway. The first part focuses on a megasynthase presenting similar 
structural and functional characteristics as the FAS (black circle in Figure 1). This multidomain 
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megaenzyme, called Polyketide Synthase (PKS), uses similar precursors, similar biosynthetic 
chemistry and similar overall architecture as FAS. But instead of producing long linear chain of 
saturated FA, PKS are able to synthetize many structurally diverse natural products that include 
plant flavonoids, fungal aflatoxins and important pharmaceutical molecules that exhibit 
antibacterial, antifungal, immunosuppressive and antitumor properties (Figure 2) [7]. Studies on 
PKS megasynthase are highly relevant for the development of new therapeutical products. The 
family of trans-acyltransferase (AT) PKS for which a stand alone acyltransferase protein delivers 
the substrate to the PKS megasynthase has became more popular for its possibility to load the 
PKS with non-natural substrates and therefore to allow the synthesis of new biologically active 
polyketides. The first part of the thesis focuses on the structural organization of the trans-AT PKS 
and the substrate delivery mechanism. 
 
 
 
Figure 2:  Chemical structure of the fatty acid Palmitic acid, a common product of the FAS, and the polyketide 6-
Deoxyerythronolide, synthesized by PKS from Saccharopolyspora erythreae and precursor of the Erythromycine antibiotic 
[8].  
 
The second part of the thesis focus on another effector of the lipid storage pathway. The 
phosphatidate phosphatase (dark blue circle in Figure 1), also called Lipin in eukaryotes, is 
responsible for the dephosphorylation of phosphatidate into diacylglycerol, the penultimate 
intermediate for TAG biosynthesis. Lipin is a key regulator in lipid metabolism as it also acts as 
transcriptional coactivators of lipid-oxidation regulating gene. More and more studies associate 
lipin with insulin resistance disorder, myoglobinury, inflammatory syndrome and alcoholic fatty 
liver disease [9, 10]. Several functional domains and many interactions with other protein 
partners have been identified; however the three-dimensional structure of the protein is still 
missing, to understand the functioning of this complex protein at a molecular level. The second 
part of the thesis presents the protein expression and purification strategy to produce soluble 
protein for biophysical and structural studies at large scale.  
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PART I: Structural Organization Of trans-AT Polyketide Synthase  
 
Type I Polyketide Synthase 
Polyketides are natural products found in bacteria, fungi and plants, which are studied for 
their therapeutic benefits such as antibiotic, immunosuppressing and antitumor activity (Figure 
3) [11]. These complex compounds are synthesized by polyketide synthases (PKS) from acyl-CoA 
precursors [12]. Current research on polyketides aims to understand the biological activity of 
these commercially and therapeutically valuable compounds as well as the remarkable 
biosynthetic mechanism and malleability of PKS, enabling the generation of a large diversity of 
polyketides. 
 
 
 
Figure 3: Structures, origins and biological activities of natural polyketides. 
 
Bacterial PKS have been classified in three classes [12] (Figure 4). Type I PKS are 
multifunctional enzymes organized into modules. Each module harbors a set of distinct 
enzymatic domains and is responsible for the catalysis of one cycle of polyketide chain elongation 
and modification. They are predominantly type II PKS are multienzyme complexes, which 
catalyses several cycles iteratively. Each domain is reused in a cyclic fashion. Type I and II PKS use 
acyl-carrier proteins (ACP) to shuttle the nascent acyl-CoA intermediates from one enzymatic 
domain to the next. Type III PKS, also known as chalcone synthase-like PKS, are essentially 
iterative and do not use ACP but directly use Coenzyme A. Despite structural and mechanistic 
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differences, all types of PKS have a Ketosynthase (KS) activity, which catalyse a decarboxylative 
condensation for polyketide chain elongation.  
 
 
 
Figure 4: Domain organization and mechanism of bacterial PKS (adapted from Shen 2003 [12]).  (A) Biosynthetic scheme 
of 6 deoxyerythronolide B, precursor of the antibiotic Erythromycin, synthesized by the modular type I PKS 6-
deoxyerythronolide B Synthase (DEBS). Polyketide intermediate is transferred from one module to the next for chain 
elongation and modification. (B) Iterative Type II PKS. The KS domain is reused in cyclic fashion. (C) ACP-independent and 
iterative Type III PKS. The KS domain is directly loaded by acyl-CoA substrates. 
 
The biosynthetic mechanism and structural organization of modular Type I PKS 
organization has been well described for the 6-deoxyerythronolide B Synthase (DEBS), which is 
responsible for the synthesis of the 6-deoxyerythronolide B, the precursor of the antibiotic 
erythromycin [8] (Figure 4). The DEBS is formed by three PKS megasynthases, each containing 
two to three modules. The minimal module for polyketide chain extension contains three 
functional domains: a ketosynthase (KS), an acyltransferase (AT) and an acyl-carrier protein 
(ACP). The minimal module can be complemented by a ketoreductase (KR), dehydratase (DH) and 
enoylreductase (ER) domains for the β-carbon modification of the intermediate polyketides. 
Three first structures of the complete mammalian fatty acid synthase (mFAS) [13] and the KS-AT 
domains from the DEBS module 3 and 5 [14, 15] supported by several other structures [16, 17] 
highlight the similar domain arrangement and chemical reaction logic of these two 
megasynthases.  
 
Similarities between mFAS and Type I PKS 
The crystal structure at 3.2Å resolution of the mFAS reveals the three-dimensional 
architecture of the domains [13] (Figure 5A). The mFAS is a homodimer in head-to-head 
arrangement connected by the malonyl-acetyltransferase (MAT)-DH linker domain. The 
condensing region composed of KS and MAT is covered by the modifying domains DH, ER and KR 
as well as the swinging ACP and the terminal Thioesterase (TE) domain. The malonyl-CoA and 
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acetyl-CoA substrates are sequentially loaded by the MAT onto the ACP and transfered to the KS 
domain (Figure 5B). The KS catalyses the decarboxylative condensation between the malonyl and 
the acetyl to produce a β-keto intermediate. The ACP transfers the β-keto intermediate to the 
modifying region for reduction and dehydratation into butyryl-ACP. The butyryl-ACP is shuttle 
back to the KS for an additional decarboxylative condensation with a malonyl substrate. The cycle 
of elongation and modification is repeated until the TE domain releases a fully saturated palmitic 
acid.  
 
 
 
Figure 5: Main characteristics of the mFAS and the standard type I PKS.  (A) Cartoon representation of the mFAS, colored 
by domains as shown in (B). The mFAS is a homodimer composed of two identical polypeptides connected by the MAT-
DH linker domain (PDB 2vz9). The condensation and the modifications regions are indicated. (B) Schematic representation 
of the structure of mFAS. The root of the ACP is indicated by grey arrows and numbering. The domains are used for 
several cycles of acyl elongation and modification. LD: Linker Domain, ME0: inactive Methyltransferase. (C) Scheme of the 
organization of the standard type I PKS 6-Deoxyerythronolide B Synthase (DEBS) responsible for the biosynthesis of 
Erythromycin. The intermediate is transfered from one module to the next. The AT loads a substrate to the ACP of the 
same module.  
 
The structure of the KS- AT homodimeric fragment from module 3 and 5 of the Type I PKS 
DEBS [14], [15] confirms the resemblance with mFAS (Figure 6). The thiolase fold KS domain is 
linked at the C-terminal to an α/β linker domain, which docks on the side of the α/β hydrolase-
like AT domain. In both megasynthase, the catalytic machinery of the KS domain is comprised of 
a Cys-His-His tryad [7] but they present different substrate specificity. The mFAS KS is highly 
specific for saturated acyl chains whereas the DEBS KS accepts β-branched intermediates [7]. A 
number of residues lining the substrate-binding tunnel of mFAS are substituted with smaller 
residues in all DEBS PKS modules, resulting in a wider, more permissive tunnel in the KS of DEBS 
[18]. The crystal structures of AT and MAT exhibit an α/β hydrolase fold with an appended 
ferredoxin-like subdomain. Both MAT and AT have a catalytic Ser-His dyad located in a groove 
between the two subdomains. The mFAS MAT displays a broad specificity for malonyl-CoA 
derivatives (e.g., propionyl-CoA and methylmalonyl-CoA). MAT are distinguished from AT by the 
presence of a conserved active site arginine, which forms a bidentate salt bridge with the 
malonyl carboxylate. Mutation of this arginine to alanine or lysine reduced malonyl transacylase 
activity and increase selectivity for acetyl-CoA, transforming the MAT into an AT [19]. The α/β 
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linker domain does not have any catalytic activities but maintains the spatial organization 
between KS and AT in order to be reachable for the substrate-binding ACP domain.  
 
 
 
Figure 6: Structure of the crystallized dimeric KS-LD-AT domain from mFAS and DEBS module 3.  (A) Structure of KS-LD-AT 
of the mFAS (PDB 2vz9). The domain annotation belong to the same monomer. (B) Structure of KS-LD-AT of the DEBS 
module 3 (PDB code 2HG4).  
 
In contrast to mFAS, modular type I PKS do not use iterative elongation, but instead, the 
polyketide intermediate is transferred from one module to the next one for chain elongation. In 
certain modular type I PKS, modules can be used in iterative manner or can be skipped during 
polyketide elongation [20]. The KS is remarkably tolerant to a diverse array of extender units, 
while the AT likely discriminates between extender units that are native to the producing 
organism [21]. The substrate specificity of AT and the variation in the domain composition of 
modular type I PKS results in the biosynthesis of very diversified products. As the modular type I 
PKS polypeptide is encoded genomically in line, the structure of the product is already encoded in 
the gene. Mutation at the gene level of the catalytic site of PKS domain would lead to the 
synthesis of a modified polyketide. This represents a non-negligible advantage for PKS 
engineering in the pharmaceutical field and the production of new bioactive polyketide.  
 
Engineering Type I PKS to produce new biologically active polyketide 
Currently, most of the available polyketide drugs are from microbial origin [22]. 
Polyketide-drug discovery efforts have traditionally taken two forms: isolation and identification 
of new compounds from the biosphere, or the semi-synthetic modification of polyketide scaffold 
by chemistry [23]. There is evidence that bacteria, terrestrial and marine invertebrates, including 
insects, molluscs and sponges are true sources for new polyketide but unculturable 
microorganisms remains a serious constrain [23, 24]. An alternative strategy has also been used 
to produce new polyketides from genetically engineering PKS. Engineering of PKS assembly lines 
by site-directed mutagenesis or combinatorial biosynthesis are attractive approaches to generate 
novel therapeutic polyketides.  
The AT is responsible for specifying and loading the appropriate CoA extender unit onto 
the ACP (e.g. malonyl-CoA, methylmalonyl-CoA or methoxymalonyl-CoA) [25]. The substrate 
specificity of the AT can be altered via site-directed mutagenesis. Site-directed mutagenesis of 
important residues has the potential to be minimally invasive, allowing the AT domain to remain 
in its native environment and causing minimal perturbation to important protein–protein 
interactions [26]. Mutation from the methylmalonyl-CoA specific YASH motif to the malonyl-CoA 
specific HAFH motif in AT of the DEBS module 1, 4 and 6 led to AT domains capable of 
incorporating both extender units [27-29]. Mutations outside of this motif have also allowed to a 
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lesser extent incorporation of the non-native extender unit. In vitro analysis of a YASH to HAFH 
motif mutant in AT of DEBS module 3 revealed that the activity of these mutants is drastically 
attenuated, implying that mutation of the catalytic site and incorporation of non-natural 
extender units results in diminished AT catalytic activity [30].  
Combinatorial biosynthesis results in the construction of hybrid PKS modules by deletion, 
addition or swapping of domains. The general applicability of this approach was demonstrated by 
the synthesis of 14 different modules from eight different PKS systems and their rearrangement 
into 154 different bi-modular combinations, suitable for E. coli expression [31]. Half of the bi-
modules generated the predicted triketide lactone product. However, each of the recombined 
modules demonstrated catalytic competence by processing unnatural substrates [31]. This 
suggests that the lack of activity displayed by some bi-module combinations is most likely due to 
faulty communication between the upstream ACP and the downstream KS of interacting modules 
[25]. Another approach replaced the AT domains in six of the seven geldanamycin PKS modules 
with a malonyl-specific AT from the rapamycin biosynthetic cluster. Four of the six hybrid 
modules successfully produced the predicted geldanamycin analogs, but in much lower yield 
relative to geldanamycin in the producing strain [32]. The use of inaccurate domain boundaries 
presumably destabilizes the modular architecture, resulting in reduced catalytic efficiency of the 
hybrid multifunctional protein. 
AT domain specificity and inter-domain connections seem to be the major limiting 
components for successful engineering of novel and functional PKS systems. An attractive target 
to bypass these two limiting factors is the family of trans-AT PKS, which exhibit an AT activity in 
trans, compared to the previously described cis-AT PKS. [33-36]. 
 
Trans-AT PKS, an attractive alternative for PKS engineering 
 Trans-AT PKS are non-canonical PKS with the same biochemical reaction logic as 
modular PKS but using external proteins (commonly AT or ER) for individual reaction steps. Trans-
AT PKS modules lack the internal AT domain of cis-AT PKS [33, 34, 36-39] and receive their acyl 
building blocks from free-standing AT enzymes acting in trans (Figure 7). In trans-AT PKS clusters, 
one to three AT proteins are encoded either on individual genes, fused as tandem ATs, or fused 
with a trans-acting ER domain into a trans-AT-ER protein (Piel 2010). In Bacillus subtilis, the trans-
AT-ER PksE co-localizes with PKS megasynthases to form a megadalton-sized PKS biosynthetic 
structure at the cell membrane [40]. This finding suggests that trans-proteins directly interact 
with other PKS components. Each trans-AT protein may functionally serve several or all ACP 
domains of a PKS assembly line. Selection of an appropriate trans-AT for combinatorial 
biosynthesis could yield diversified polyketide products. Trans-AT PKS are also of particular 
interest for PKS engineering as they often integrate domains of the non-ribosomal peptides 
synthetase (NRPS) family in their assembly line. The adenylation domain (A) and the 
condensation (C) domain of the Brevibacillus brevis (B. brevis) trans-AT PKS incorporate an amino 
acid in the newly synthesized polyketide (Figure 7).  
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Figure 7: Schematic view of the cis-AT PKS DEBS and the hybrid NRPS/trans-AT PKS PKS C0ZGQ5 from B. brevis. C, 
Condensation domain, A, Adenylation domain.  
 
Aim of Research: Insight into the mechanism of substrate delivery of trans-AT PKS  
Trans-AT PKS are an attractive target for protein engineering and synthesis of new 
bioactive polyketide compounds. External proteins might be easier to modify or exchange than 
the intact PKS modules. However, the transfer of substrate between the trans-AT-ER proteins 
and the core KS-containing multienzyme component of trans-AT PKS may require specific 
interaction interfaces, which have not been elucidated so far. The aim of my research project was 
to study the interaction interface between a trans-AT KS domain and a trans-AT-AT-ER protein. I 
worked on B. brevis trans-AT PKS and used structural and biophysical approaches. X-ray 
crystallography was used to determine the crystal structure of the KS domain with its N-terminal 
linker from the module 2 of B. brevis trans-AT PKS and to study the potential docking interface 
for the trans-AT-AT-ER. KS and linker domains from trans-AT PKS were analysed by sequence 
alignment to determine component important for the structural organisation of the trans-AT PKS 
and interaction site with the trans-AT-AT-ER protein. Surface Plasmon Resonnance, Microscale 
thermophoresis and Analytical Ultracentrifugation were used to study protein-protein interaction 
between wild type/mutated KS domain and several constructs of the B. brevis trans-AT-AT-ER. 
Oligomeric state of the trans-AT-AT-ER protein was characterized by size-exclusion 
chromatography coupled to multi-angle light scattering (SEC-MALS) to give information of the 
organization of trans-AT-AT-ER protein from trans-AT PKS.  
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Part II: Lipin, A Key Regulator In Lipid Metabolism 
 
The lipin family 
Lipin is a bi-functional protein involved in lipid metabolism and adipogenesis. Lipin acts as 
phosphatidate phosphatase (PAP) in the triacylglycerol synthesis pathway and as transcriptional 
coactivator of the lipid-oxidation regulating gene [41]. The triacylglycerol synthesis or Kennedy 
pathway consists of sequential reactions starting from glycerol-3-phosphate and ending with 
triacylglycerol (TAG). Lipin catalyses the penultimate step by converting phosphatidic acid (PA) to 
diacylglycerol (DAG) (Figure 8). The phosphatidate phosphatase (PAP) activity of Lipin plays a 
crucial role in lipid homeostasis by controlling the relative proportions of its substrate PA and 
products. PA is a potent activator of MAP kinase/Erk, an inhibitor of mTORC2 (mammalian target 
of rapamycin complex 2) activity, a repressor of the UASino regulated genes and it regulates 
inflammatory signaling pathways [1], whereas DAG level regulates several signal transduction 
pathways through the activation of protein kinase C and protein kinase D. DAG is then used for 
the synthesis of the most abundant phospholipids phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) and for the synthesis of triacylglycerol (TAG) [41]. TAG is critical for 
long-term energy storage in adipose tissue and provides a source of fatty acids for oxidation in 
skeletal muscle and cardiac muscle. In the other branch of the Kennedy Pathway, PA is converted 
to cytidine di-phosphate diacylglycerol (CDP-DAG) that gives rise to phosphatidylinositol (PI), 
phosphatidylserine (PS), PE and PC. The regulation of lipin activity determines the distribution of 
the glycerol backbone between the two branches of the pathway [41].   
 
 
Figure 8: Simplified scheme of the role of lipins in the de novo phospholipid biosynthetic pathways.  Glycerol 3-phosphate 
is converted through a series of acylations with fatty acids into lysophophatidic acid (LPA) and phosphatidic acid (PA). PA 
is a key precursor that is used, through its conversion to diacylglycerol (DAG), for the synthesis of triacylglycerol (TAG) and 
the major phospholipids phosphatidylethanolamine (PE) and phosphatidylcholine (PC). In the other branch of the 
pathway, PA is converted to cytidine di-phosphate diacylglycerol (CDP-DAG) which then gives rise to phosphatidylinositol 
(PI), and Phosphatidylserine (PS), PE and PC. PA is involved in cellular signaling by inhibiting mTORC2 and activating 
MAPK/Erk pathways. DAG activates protein kinase C (PKC) and protein kinase D (PKD).  
 
Lipin expression has been shown in human [42], mouse [43], plants [44], insects [45], 
parasitic protozoan [46] and is referred to PAH1 for the yeast homologue [47]. All lipin members 
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contain the DxDxT motif for the phosphatidate phosphatase activity (PAP) as well as two 
extended stretches of highly conserved amino acid sequences at the amino- and carboxy-
terminus, called as N-LIP and C-LIP (Figure 9). The yeast PAH1 presents the C-LIP in a central 
position.  
 
 
 
Figure 9 : Mapping of the functional domains on Lipin 1 and ScPAH1. The conserved N-LIP and C-LIP domains are in 
yellow, the DxDxT catalytic site for PAP activity is in orange, the binding sites for protein are in blue and the 
transcriptional activation domain in green. The position of exon insertion for the β and γ isoforms are indicated on lipin 1. 
 
Human and mouse encode three isoforms lipin 1, 2 and 3 [48]. Gene-expression studies 
have shown that these isoforms have particular expression profiles depending on the tissues [1] 
(Figure 10). Different lipins within the same tissue can compensate for each other in some 
settings but not others [1, 49]. In mouse, a broad set of tissues express lipin 1, but the enzyme is 
predominantly found in muscle and adipose tissue. Lipin 2 is expressed at highest level in liver 
and brain, and at lower level in the gastrointestinal tract and bone. Lipin 3 expression is generally 
much lower with the highest expression in small intestine and bones [1]. The three lipin possess 
PAP activity, but the intrinsic enzymatic activity varies dramatically (maximal velocity Vmax of 
lipin 1 >> lipin 2 > lipin 3) [50]. 
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Figure 10: Mouse lipin expression profile (adapted from (Csaki et al., 2013)). The diagram indicates the relative levels of 
lipin 1, lipin 2 and lipin 3 mRNA expression in mouse tissues.  
 
Lipin 1 can form hetero-oligomers in combination with lipin 2 or lipin 3 [48]. The 
oligomerization state of the lipin1 does not influence the PAP activity. Both the N- and C-terminal 
regions of lipin 1 mediate its oligomerization in a head-to-head/tail-to-tail manner. Size-exclusion 
chromatography suggests the tretramerization of lipin 1 [48] whereas atomic force microscopy 
on a lipid bilayer surface suggests an assembly from monomeric lipin to larger dodecameric 
complexes [51].  
Lipin 1 is the most biochemically and pathophysiologically characterized member of the 
lipin family. Alternative splicing of the lipin 1 transcript gives rise to three distinct lipin 1 proteins 
(lipin 1α, lipin 1β and lipin 1γ).  Lipin 1β contains 36 additional amino acids downstream the N-LIP 
while lipin 1γ has 26 additional residues upstream the C-LIP. Each splicing isoform has a unique 
cellular localization and intrinsic PAP activity [42, 52]. Lipin 1α appears to be predominantly 
nuclear, whereas lipin 1β resides mostly in the cytoplasm suggesting distinct cellular functions 
[52]. Lipin 1α is required for adipocyte differentiation whereas the major effect of lipin 1β 
expression is the induction of lipogenic genes [52]. The PAP activity of purified lipin 1α and lipin 
1β is comparable, but their relative activity differs between two published studies that used 
different methods to purify lipin 1 [42, 50]. The PAP activity of lipin 1γ is almost negligible [42] 
but it has been shown to be the main lipin 1 isoform expressed in human brain suggesting a 
specialized role in regulating brain lipid metabolism [53]. Lipin 1β co-immunoprecipitates with 
lipin 1β, 1α, 2 and 3 [48] indicating the formation of homo- and hetero-oligomers. 
 
Lipin, a phosphatidate phosphatase 
Lipin is specific for PA and requires Mg2+ for PAP activity [42]. PA substrates containing 
1,2-di-unsaturated and 1-saturated-2-unsaturated fatty acyl groups are equally good substrates 
for lipin 1 [42]. Among the substrates with unsaturated fatty acyl groups, the chain length (from 
C16 to C22) and the degree of unsaturation (from one to six double bonds) had little effect on the 
activities of lipin 1α, β and γ, but PA molecules with only saturated fatty acyl groups were poor 
substrates [42]. Lipin 1 catalyzes the PAP reaction based on a DxDxT motif within a haloacid 
dehalogenase-like domain [42]. The PAP activities of the ExDxT and DxExT mutant enzymes in 
yeast PAH1 were reduced by more than 99.9% [54].  
Cells lacking the PAH1-encoded PA phosphatase activity contain an elevated level of PA 
and exhibit the derepression of the inositol-sensitive upstream-activated sequence (UASINO)-
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containing phospholipid synthesis genes. When the levels of PA are high, the inhibitor Opi1p is 
excluded from the nucleus by binding to PA on the ER membrane and Ino2p-Ino4p activates the 
transcription of several phospholipid synthesis genes [55]. The yeast DAG kinase 1 (DGK1) 
counterbalances the function of PAH1 by phosphorylating DAG to PA (Figure 11). Cells bearing a 
DGK1 mutation do not exhibit any remarkable phenotypes under standard growth conditions. 
However, like the pah1 mutation, overexpression of DGK1 causes the accumulation of PA at the 
nuclear/ER membrane and the derepression of UASINO-containing genes [56].  
 
 
 
Figure 11: Scheme of the role, regulation and cellular localization of lipin 1. Lipin1 translocate from the cytosol to the ER 
membrane and the nucleus depending on its phosphorylation and sumoylation state. In the ER membrane, lipin 1 
dephosphorylates phosphatidate to diacylglycerol whereas in the nucleus, lipin activates several transcription factors.  14-
3-3: 14-3-3 protein, CTP:  Cytidine triphosphate, DAG: Diacyglycerol, DGK1: Diacyglycerol kinase 1, LPA: 
Lysophosphatidate, MEF2:  Myocyte enhancer factor-2, NFATc4: Nuclear factor of activated T cells, P: Phosphorylation, 
PA: Phosphatidate, PGC1α: PPARα coactivator 1α, PPARα: peroxisome proliferator-activated receptor α, S: Sumoylation, 
SREBP1: Sterol regulatory element binding protein, TAG: triacyglycerol, +: activation, - : inhibition.  
 
To exert its PAP activity, lipin transiently translocates from the cytosol to the ER 
membrane where it dephosphorylates PA to DAG. Membrane association of lipin 1 is dependent 
of phospholipid composition and pH [57]. Phosphatidylethanolamine increases activity and 
binding of Lipin 1 to PA-containing liposomes presumably via electrostatic attraction. Lipin 1 
preferentially binds di-anionic PA through a nine amino-acids KKRRKRRRK polybasic domain 
(PBD) [57]. In Saccharomyces cerevisiae conserves a KKKEK region in a similar position but the 
Saccharomyces pombe homolog does not contain more than two consecutive basic amino acids. 
The Arabidopsis thaliana homolog also lacks a PBD and yet functions similarly to yeast PAH1 [58]. 
Evolutionarily, the nine-amino acid PBD found in mammals did not occur until Ciona intestinalis 
and is largely conserved in all descendant species [57]. Instead, the yeast ScPAH1 contains an 
amino-terminal amphipathic helix (amino acid 1 to 18) that is required for membrane 
recruitement and PAP activity after dephosphorylation by Nem1p-Spo7p [59]. The helical 
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arrangement brings six residues in contact forming a hydrophobic phase (Met1, Val4, Leu8, 
Val11, Try15, Iso18). Deletion of these 18 amino acids as well as the mutation to alanine of four 
bulky residues (Met1, Val4, Leu8 and Try15) abolishes recruitment to the membrane. Mammalian 
lipin contains predicted amphipathic helices at their amino terminus, but whether the helix is 
required for membrane association has not been determined [57]. The PBD motif of mammalian 
lipin may be specific for PA association, whereas the amphipathic helix of yeat PAH1 is more 
likely involved in general membrane binding [60]. Interestingly, deletion of the KKRRKRRRK motif 
in lipin 1 impairs its membrane association and its nuclear import; identifying the role of the 
same sequence in both membrane binding and nuclear localization [61, 62].  
 
Lipin, a transcriptional coactivator 
The nuclear localization signal (NLS) is required for the translocation of lipin 1 to the 
nucleus where it interacts with a large set of transcription factors [62] (Figure 9). Lipin 1 activates 
mitochondrial fatty acid oxidation via activation of peroxisome proliferator-activated receptor α  
(PPARα) and peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1 α  (PGC-1 α) [63] 
(Figure 11). Lipin 1 physically interacts through its C-terminal LxxIL motif with the C-terminus of 
PPARα [63]. Mutation to LxxFF of lipin1 severely attenuated its interaction with PPARα. Lipin1 
also regulates the transcriptional activity of PPARγ [64], a transcription factor involved in 
adipogenesis through the regulation of adipocyte-specific gene expression. The C-terminal VxxLL 
motif of Lipin 1 is critical for PPARγ binding while the central transcriptional activation domain 
(TAD, residues 217 to 399), is critical for PPARγ activation. The TAD includes the region 
corresponding to the additional exon 7 of the Lipin 1 β [64]. Interestingly, lipin1β showed more 
potent PPARγ activating capacity than lipin 1α. Lipin 2 and 3 conserve the LxxIL for PPARα binding 
[65] and both isoforms also conserve the VxxLL motif in C-LIP region for PPARγ-binding. However, 
they do not have any sequence homology to the TAD [64]. Accordingly, Lipin 2 is able to activate 
PPARα similarly to lipin1 but did not affect PPARγ activity [64]. The VxxLL motif by itself may be 
not sufficient to make lipin 2 and 3 an activator of PPARγ. This finding suggests that lipin1 has a 
unique function of activating PPARγ transcriptional activity.  
Lipin 1 also regulates several others factor like the myocyte enhancer factor 2 (MEF2), the 
nuclear factor of activated T-cells c4 (NFATc4) and the sterol response element binding protein 1 
(SREBP1) [1]. Therefore, Lipin 1 influences important metabolic processes involved in activation 
of fatty acid oxidation genes, adipocytes differentiation and adipocyte inflammatory gene 
expression.  
 
Regulation and subcellular localization of Lipins 
Lipin translocates from the cytosol to the ER membrane or the nucleus to exert its 
functions. Translocation and activity of lipin is regulated by several mechanisms involving 
phosphorylation, sumoylation and interaction with proteins like 14-3-3 protein and PP-1cγ.  
Phosphorylation of lipin causes its relocation from the ER membrane and nucleus to the 
cytosol and attenuates its PAP and transcriptional cofactor activities. The yeast PAH1 is 
phosphorylated on seven sites (Ser110, Ser114, Ser168, Ser602, Thr723, Ser744, and Ser748) by 
the proline-directed protein kinases Pho85p-Pho80p [66], of which three sites (Ser602, Thr723, 
Ser744) are also the targets for the Cdc28p-cyclin B [67]. Protein kinase A also phosphorylates 
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PAH1 on Ser10, Ser677, Ser773, Ser774 and Ser788 [68]. Phosphorylation by Pho85p-Pho80p 
results in a reduced catalytic efficiency of PAP [66], whereas activity is not affected by 
phosphorylation via Cdc28p-cyclin B [67]. The protein kinase A-mediated phosphorylation of 
PAH1 inhibits its PAP activity by decreasing catalytic efficiency, albeit to a lesser extent compared 
to Pho85p-Pho80p [68]. A seven alanine mutant enzyme, where the seven (Ser/Thr)-Pro target 
sites of Pho85p-Pho80p are mutated to nonphosphorylatable alanine, exhibits elevated PAP 
activity. Simultaneous mutation of the three Cdc28p-cyclin B phosphorylation sites (3A) only 
partially mimics the physiological consequences of the seven alanine mutations [67]. The protein 
kinase A-mediated phosphorylation of Ser10 functions in conjunction with the phosphorylations 
mediated by Pho85p-Pho80p and Cdc28p-cyclin B. The Ser10Ala mutation enhances the 
physiological effects caused by the seven alanine mutations, whereas the Ser10Asp mutation, 
which mimicks phosphorylation, attenuates the effects of the seven alanine mutations. 
Phosphorylation of PAH1 by other kinase like protein kinase C and casein kinase II decreases its 
interaction with model membranes, further suggesting an inhibitory effect of phosphorylation on 
PAP activity [69]. Taken together, lipin undergoes a complex mechanism of phosphorylation 
modulating its PAP activity and cellular localization.  
Cytosolic lipin is hyperphosphorylated. Hyperphosphorylated lipin associates in the cytosol 
with the 14-3-3 protein, which blocks its translocation to other compartment [70]. 14-3-3 protein 
characteristically binds to target proteins possessing recognition motifs consisting of 
phosphoserine followed by proline in the +2 position. Lipin 1 contains several of these motifs in a 
Serine Rich Domain (SRD amino acid 218-260). Structurally complex interactions between 14-3-3 
and lipin 1 involve multiple phosphorylated and non-phosphorylated residues within the SRD.  
 Dephosphorylation of lipin enhances its activities by allowing translocation to the ER 
membrane and the nucleus. The human lipin is dephosphorylated by the C-terminal domain 
nuclear envelope phosphatase 1 (CTDNEP1, formerly “dullard”) in complex with nuclear envelope 
phosphatase 1-regulatory subunit 1 (NEP1-R1) [71] while the yeast PAH1 is dephosphorylated by 
the transmembrane protein phosphatase complex Nem1p-Spo7p [72]. Only dephosphorylated 
Lipin 1 can bind to the Ser/Thr protein phosphatase 1 catalytic unit γ (PP-1cγ) through a HRVF 
motif [73]. A mutation of the HRVF binding motif in lipin 1 to HARA abrogates the interaction 
with PP-1cγ as well as its nuclear translocation and the phosphatidate phosphatase activity. Lipin 
2, 3 and PAH1 also contain the HRVF motif [73]. Sumoylation of lipin is also necessary for the 
translocation of Lipin to the nucleus. Mutating the two sumoylated residues (Lys566 and Lys596) 
of lipin 1 impairs its nuclear localization [74]. In conclusion, different levels of regulation may act 
on the same enzyme to modulate its activity.  
Recent studies placed Lipin 1 under the control of insulin. Insulin increases lipin 1 
phosphorylation on multiple sites and the ratio of cytosolic lipin [75]. However, insulin does not 
affect the PAP-specific activity measured in immune complexes isolated from insulin-stimulated 
fibroblasts cells using lipin antibodies [75]. Insulin controls lipin primilarly by changing localization 
through phosphorylation rather than intrinsic PAP activity. A complementary study shows that 
lipin is phosphorylated in a rapamycin-sensitive manner in response to insulin in rat adipocytes, 
indicating that lipin is under the control of the mammalian target of rapamycin complex 1 
(mTORC1) [76]. More precisely, mTORC1 restrains Nem1p function by favoring the 
dephosphorylated state of Ser195 in Nem1p and potentially other unidentified residues. Nem1p 
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in complex with Spo7p is responsible for PAH1 dephosphorylation in yeast. By restraining 
Nem1p, mTORC1 favors the phosphorylated form of lipin. Finally, a study shows that insulin 
stimulated-phosphorylation enhances interaction of lipin 1 with 14-3-3 protein and promotes its 
cytoplasmic localization [70].  
Lipin 1 is subject to a high degree of phosphorylation-mediated regulation. However, the 
mechanism of regulation is also not shared by all members of the lipin family. Lipin 2 
preferentially binds di-anionic PA but has a lower rate of catalysis [77]. Like lipin 1, lipin 2 is highly 
phosphorylated. However, unlike lipin 1, phosphorylation of lipin 2 is not induced by insulin 
signaling nor is it sensitive to inhibition of the mammalian target of rapamycin [77]. 
Phosphorylation of lipin 2 does not negatively regulate either membrane binding or PAP activity 
suggesting that lipin 2 functions as a constitutively active PA phosphatase in stark contrast to the 
high degree of regulation for lipin 1 [77]. This knowledge of lipin 2 highlights the complexity of 
the function and regulation of the lipin family.  
 
Lipin mutations, polymorphisms and associated diseases 
An increasing amount of studies shows an involvement of lipin 1 in disease development. 
Mutation of lipin can affect the multiple functions of this protein but can also create a nice 
environment for pathogen development.   
Originally, lipin 1 has been identified after a spontaneous complex gene rearrangement in 
laboratory mice [78]. These mice presented lipodystrophy, insulin resistance, peripheral 
neuropathy and neonatal fatty liver referred as fatty liver dystrophy (fld) (Reue, 2009). A single 
mutation Gly84Arg in mouse lipin 1 is able to produce the exact same phenotype as the fld 
mouse [43]. Humans carrying loss-of-function mutations in lipin1 do not exhibit the extreme 
lipodystrophy observed in fld mice. However, recent studies demonstrated that perturbations in 
lipin1 expression in humans result in rhabdomyolysis, weakness and myoglobinuria in children 
while polymorphisms studied in multiple human cohorts have been associated with body mass 
index disorder and insulin insensitivity [1, 79].  
Mutation S734L in lipin 2 induces a different phenotype called Majeed syndrome, which is 
characterized by osteomyelitic lesions and dyserythropoeitic anemia [1, 65].  The lipin isoforms 
have different expression profiles, which may explain the different phenotype induced by lipin 1 
and lipin 2 mutations [1]. 
Lipin 1 has been identified to play a role in the mechanisms causing HIV-associated 
lipodystrophy (HAL) [80] as well as alcoholic fatty liver disease (AFLD) [10]. The deletion of 
the PAH1 in yeast causes expanded ER membranes providing enhanced subcellular environment 
that may be exploited for replication of positive-RNA viruses [81].  
 
Aim of the research work  
Lipin plays a complex role in lipid metabolism. It catalyses the transformation of PA to 
DAG at the ER membrane but it also interacts with several transcriptional factors to regulate lipid 
metabolism gene expression. So far, the structure of lipin is still missing to understand at a 
molecular level the interaction interface with its protein partners and the influence of mutations 
leading to disease development. The aim of my research project was to establish a purification 
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protocol for the lipin and the fungi PAH1. The purified protein enabled initial studies of structure 
and function using biophysic methods.  
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STATEMENT OF MY OWN CONTRIBUTION 
 
I cloned, expressed, purified and crystallized the KS2-LD fragment from Brevibacillus 
brevis. I determined the crystal structure with the help of Timm Maier and Dominik A. Herbst.  
Roman Jakob cloned, expressed, purified, crystallized and determined the crystal structure 
of the MlnA-ER. He perfomed and analysed the SAXS data on MlnA-ER. 
I cloned, expressed and purified several constructs of the trans-AT-AT-ER from 
Brevibacillus brevis. I tested these constructs for protein interaction experiments with wild type 
and LD-mutant BbKS2-LD using Microscale thermophoresis, Surface plasmon Resonnance and 
Analytical Ultracentrifugation.  
I prepared and analysed the oligomeric states of several contructs from trans-AT PKS by 
SEC-MALS.  
  I analysed BbKS2-LD structure by structural comparison and sequence alignment with 
other KS-LD structure from FAS, cis-AT PKS and trans-AT PKS as presenting in the Results & 
Discussion.  
 The manuscript was written by myself, Roman Jakob and Timm Maier.  
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ABSTRACT 
 
Trans-acyltransferase (trans-AT) modular polyketide synthases (PKS) catalyze the 
biosynthesis of a wide range of bioactive natural products. Each PKS module possesses a 
ketosynthase (KS) to catalyze chain elongation and the substrate to each module is delivered by 
free-standing trans-acyltransferase and enoyl reductase containing enzymes (AT-ER). To 
understand the interplay between the PKS megaenzymes with trans-AT-ER proteins, we report a 
structural and biophysical characterization of the KS from the second module of a trans-AT PKS of 
Brevibacillus brevis (Bb-KS2) and the ER domain from the MlnA trans-AT-ER protein (MlnA-ER) of 
the Macrolactin biosynthesis cluster of Bacillus amyloliquefaciens. The structure of Bb-KS2 
revealed in addition to catalytic active thiolase domain a flanking linker domain (LD) with a 
characteristic helical triangle organization. Comparison with to ketosynthases identified distinct 
classes of the linker domain in trans-AT PKS. The structure of MlnA-ER demonstrates the dimeric 
architecture of trans-AT ER and revealed large expansion segments. The small-angle x-ray 
scattering analysis of AT-ER proteins suggests an arch-like molecule, with the ER dimer building 
the center and the AT the ends of the arch. 
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INTRODUCTION 
Modular type I polyketide synthases (PKS) are microbial biosynthetic multienzymes 
producing potent natural products such as antibiotics [82, 83], the immunosuppressant 
rapamycin [84], and the antitumor drug epothilone B [85]. Type I PKS are organized into modules, 
responsible for one precursor elongation step [12, 83, 86]. Modules are integrated into a dimeric 
polypeptide, and several of these are tethered via linking domains to form one giant assembly 
line [87, 88]. The individual modules are variations of a common set of domains shared with 
animal fatty acid synthase [7, 18, 89]:  An acyl transferase (AT) loads the acyl-moiety of acyl-
coenzyme A (CoA) derivatives onto the acyl carrier protein (ACP). The ACP-bound intermediate is 
then shuttled to the ketoacyl synthase (KS) domain for chain elongation via decarboxylative 
condensation followed by β-carbon modification steps, catalyzed by ketoreductase (KR), 
dehydratase (DH) and enoyl reductase (ER) domains. The functional organization of such 
canonical or cis-AT PKS is represented also at the architectural level: The dimeric KS and the AT 
domain are connected by an α/β-fold linker domain (LD) and together built the well-conserved 
condensing part of a module, which is flexibly linked to a more variable part containing the β-
carbon modification domains.    
The chemical composition of a polyketide product is directly encoded in the primary 
structure of the PKS: individual modules carry out a single or occasionally a defined number of 
precursor elongation step before passing the product to the next module in sequence [7]. 
Product diversity is obtained via varying substrate specificities of AT domains and by altering the 
set of β-carbon modifying domains in each module [90, 91]. The minimal module consists of KS-
AT-ACP domains and produces a β-keto intermediate, while KS-AT-KR-ACP, KS-AT-DH-KR-ACP and 
KS-AT-DH-ER-KR-ACP modules yield hydroxyl-, enoyl- and fully saturated acyl products in their 
respective elongation steps [90, 92].  
Currently, most of the available polyketide drugs are from microbial origin. Re-engineering 
of PKS assembly lines [22, 25, 93] can yield novel therapeutic polyketides [23, 24, 30, 31, 94-98]. 
However, the success of engineering artificial PKS systems has been limited so far; likely due to 
defective inter-domain connections and non-matched domain specificities. 
 Trans-AT PKS are an attractive alternative target for combinatorial biosynthetic 
approaches [33, 34, 36, 99]. Here, PKS modules receive their acyl building blocks by dissociated 
AT proteins in trans; they lack the internal AT domain of cis-AT PKS [33, 34, 36-39] and may have 
evolved independently of cis-AT PKS [38]. Typically, in trans-AT PKS one to three AT proteins are 
encoded per trans-AT PKS gene cluster, either on individual genes, fused as tandem ATs, or most 
commonly fused with a trans-acting ER domain into a trans-AT-ER protein (Piel 2010). Each trans-
AT protein may functionally serve several or all ACP domains of a PKS assembly line. Thus, 
selection of an appropriate trans-AT for combinatorial biosynthesis could yield diversified 
polyketide products. Trans-AT proteins may directly interact with other PKS components, as 
demonstrated for PksE, a trans-AT-ER protein of Bacillus subtilis, which co-localizes with PKS 
megasynthases to form a megadalton-sized PKS biosynthetic structure at the cell membrane [40].  
 Trans-AT proteins are monomeric approx. 35kDa proteins as exemplified by the 
representative structure of DszD/DisD from the Disorazol biosynthesis cluster [100] and resemble 
the internal AT domains of cis-AT PKS. In contrast, the trans-ER proteins adopt a completely 
different fold than cis-AT PKS internal ER domains: trans-ER are distantly related to the non-
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canonical FMN-containing TIM-barrel ER FabK from bacterial fatty acid biosynthesis [101], while 
cis-AT PKS ER domains belong to the MDR family of short-chain dehydrogenases [102]. Compared 
to FabK, trans-AT-ER domains are about 50% larger, due to insertions to the core fold of 
unknown structure and function. Thus, the most common type of AT-ER proteins consists of a N-
terminal 300 amino acids (aa) AT domain, which is connected via a linking region to a 450aa C-
terminal ER domain.  
In an effort to study the interplay between the core KS-containing multienzyme 
component of trans-AT PKS with trans-AT-ER proteins, we report here a structural and 
biophysical characterization of the KS and linking region from the second module of a trans-AT 
PKS of Brevibacillus brevis (Bb-KS2) and the ER domain from the MlnA trans-AT-ER protein (MlnA-
ER) of the Macrolactin biosynthesis cluster of Bacillus amyloliquefaciens. Bb-KS2 is the first 
structurally characterized KS domain of a trans-AT PKS pipeline, which precedes a DH domain. 
Comparison with other trans-AT KS structures reveals a unique organization of the lateral linking 
region, and identifies distinct classes of trans-AT KS based on the conservation of core fold 
extensions. The dimeric structure of MlnA-ER, a representative of trans-AT-ER ER domains 
revealed extensions to the core fold positioned for supporting higher order protein-protein 
interactions in trans-AT PKS. Together with Small-angle X-ray scattering (SAXS) characterization 
we can deduce a plausible solution model for trans-AT-ER proteins. 
 
RESULTS & DISCUSSION  
To analyze the structural basis for the interplay between core trans-AT PKS and external 
trans-acting AT-ER proteins, we have cloned, expressed and purified core KS-domains including 
adjacent linker regions as well as AT-ER proteins from a series of microbial trans-AT assembly 
lines. The purified proteins were subjected to structural studies and interaction assays.  
 
Bb-KS2-LD, a trans-AT KS region of a large Brevibacillus brevis NRPS/PKS 
Soil-living gram-positive Brevibacillus brevis (B. brevis) is a producer of several 
nonribosomal peptides, including the antibiotics gramicidin and tyrocidine [103, 104]. In addition 
to several NRPS clusters, B. brevis contains one mixed NRPS/PKS cluster of about 99 kbp in size, 
for which no product has been described, yet. This cluster contains six megasynthase 
polypeptides, comprising a total of two NRPS and fourteen PKS modules (Figure S 1). The largest 
megasynthase of the cluster  (Uniprot ID: C0ZGQ5) is 7146 amino acids in length and harbors an 
N-terminal NRPS module followed by five trans-AT PKS modules. The KS containing region (aa. 
2314-2940) of module 2 of C0ZGQ5 was recombinantly expressed in Escherichia coli (E. coli), 
purified and crystallized (Figure 12 and Figure S 1). The structure was solved by molecular 
replacement using the KS domain from DEBS module 5 (DEBS-KS5) [15] and refined at 2.0 Å 
resolution (Table S 1). The crystallized fragment (Bb-KS2-LD) comprises the KS domain (Bb-KS2, 
aa. 2321-2760) and a large C-terminal extension (Bb-LD), with a compact α/β-fold (aa. 2761-
2933), which links it in the intact PKS to the downstream DH domain (Figure 13).  
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Figure 12: Schematic view of the domain organization of the DEBS cis-AT PKS and the B. brevis trans-AT PKS. (A) Domain 
organization of the cis-AT PKS from the 6-deoxyerythronolide (DEBS) operon in Erythromycin. The three multidomain 
proteins DEBS1, DEBS2 and DEBS3 associate together by N- and C-terminal linker domains, indicated by the dashed line. 
(B) Domain organization of the trans-AT PKS C0ZGQ5 from B. brevis and the external substrate loading and enoyl-
reductase protein AT-AT-ER C0ZGR0. The crystal structure of KS domain of module 2 of C0ZGQ5 (shown in grey frame) 
was determined. Black circles indicate the position of the conserved KS-AT linker. AT, Acyltransferase; ACP, Acyl Carrier 
Protein; KS, Ketosynthase; DH, Dehydratase; ER, Enoyl reductase; KR, Ketoreductase; TE, Thioesterase; C, Condensation 
domain; A, Adenylation domain. 
 
Bb-KS2 adopts a thiolase fold observed in all KS domains from fatty acid and polyketide 
synthases (Figure 13 and Figure S 2) with a canonical catalytic Cys-His-His (Cys2496, His2631 and 
His2671) triad (Figure S 3A) [7] and belongs to clade VIII of KS domains [103] (Table S 2 and Table 
S 3). Methionine 2495 narrows the substrate binding cleft and renders Bb-KS2 specific for β-
unbranched substrate like malonyl-CoA [38, 105, 106] (Figure S 3B and D). Sequence-based 
methods predict the precursor transferred from the preceding module 1 to Bb-KS2 as a β-
hydroxyacyl moiety [103] connected to an alanine that is introduced by the NRPS starter module 
[107] (Table S 3). The length and composition of the alanine-containing-β-hydroxyacyl precursor 
is unknown, as this PKS cluster from B. brevis is not annotated. C0ZGQ5 PKS may receive a 
polyketide intermediate from other PKS of the same cluster (Figure S 1). Comparison of Bb-KS2 
with the co-crystal structure of the β-ketoacyl-(acyl-carrier-protein) synthase I (KASI) from E. coli 
in complex with a C12 substrate [108] demonstrates that Bb-KS2 could accommodate even larger 
than C12 substrates (Figure S 3C and D).  
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Figure 13: Overall structure of the dimeric B. brevis KS2 and comparison to other PKS ketosynthases. (A) Structure of the 
trans-AT Bb-KS2. N- and C-terminus are indicated as circles. The annotation of the KS and LD domains and the position of 
the preceding ACP and following DH domains belong to the same monomer. (B) Structure of the KS, LD and B domain of 
the dimeric trans-AT PKS RhiE (PDB code 4KC5). (C) Structure of the KS, LD and AT domains of the dimeric cis-PKS DEBS 
module 3 (PDB code 2HG4). KS, LD, AT, and B domains are annotated and colored in orange, grey, red, and purple, 
respectively. 
 
Extensions of the KS core fold in Bb-KS2-LD 
Bb-KS2 adopts the canonical dimeric KS structure characterized by a central ten-stranded 
sheets. They are formed by antiparallel β-strands donated from both protomers (Figure S 4A). A 
cap region composed of three α-helices, A, B & C (Figure 14A) additionally contributes to 
dimerization and provides 30 % of the total dimer interface. Helix A of the cap region is highly 
conserved in all PKS, FAS and KAS I & II ketosynthase, while helix B is present in all systems 
except in DEBS (Figure 14 and Figure S 2). In Bb-KS2, the N-terminal ends of helices B restrict the 
substrate binding cavities (Figure S 3B), while residues at the C-terminal end of these helices, 
Asp2458 and Lys2461, form two interchain salt-bridges across the dimer interface (Figure S 4B). 
The highly conserved dimeric interface of ketosynthases in trans- and cis-AT PKS [14, 15], 
demonstrates that overall dimeric architecture of the PKS assembly line is conserved in both 
families. 
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Figure 14: Comparison of the extensions of the core fold of Bb-KS2 with PKS, FAS and KAS II. (A) Characteristic extensions 
of Bb-KS2. The three α-helices of the cap domain are colored in different shade blue and annotated helix A (aa. 2529-
2538), B (aa. 2452-2462) and C (aa. 2370-2376). The α-helix and the β-sheet extensions localized at the vicinity of the N-
terminus (indicated by N in orange circle) of the KS domain are colored in green and red respectively. One α-helix 
extension of one monomer is localized at the back of Bb-KS2 structure. The dimer interface is indicated by a grey dash 
line and the domain annotations correspond to the same monomer. (B) Extensions of the KS dimer from the trans-AT PKS 
RhiE (PDB code 4KC5). One β-sheet extension of the RhiE was not built because of low electron density. (C) Extensions of 
the KS dimer from the module 5 of the cis-AT PKS DEBS (PDB code 2HG4). (D) Extensions of the KS dimer from the pFAS 
(PDB code 2VZ9). (E) Extensions of the KS dimer from the E. coli KAS II (PDB code 1KAS). 
 
Helices A and B are structurally conserved in the recently determined crystal structures of 
the trans-AT PKS KS domain RhiE [109] and PksK [103], but helix C is specific for Bb-KS2 (Figure S 
2). A hint towards the function of helix C is provided by comparison to RhiE: The corresponding 
sequence region of RhiE forms a loop, which is involved in interactions with the adjacent B 
domain (Figure S 5A). This B domain is a homologue of the DH domain, which follows Bb-KS2 in 
the intact assembly line. Thus helix C, together with an adjacent loop, might form a docking 
platform for the upstream DH domain in the full length PKS, presumably via a set of accessible 
charged residues (Asp2363, Glu2367, Asp 2369, Lys2372, Glu2376 and Lys 2378) (Figure S 5).  
Two additional extensions localize to the vicinity of the N-terminus, the anchor point for the ACP 
domain of the preceding module in the intact assembly line (Figure 14). First, a short α-helix (aa. 
2571-2577, green in Figure 14) is conserved in PKS, bacterial KS and fungal FAS KS, but not in 
animal FAS (Figure S 2). Sequence alignment of this helical insertion reveals a LxxAxxD motif 
shared by 79 out of 99 KS domains from trans-AT PKS (Figure S 6) (Table S 3 and Table S 4). The 
second extension in the vicinity of the N-terminus is a β-hairpin (aa. 2725-2737, red in Figure 14), 
which is absent in the cis-PKS DEBS, the eukaryotic and bacterial FAS (Figure S 2). The occurrence 
of a characteristic PxxxxxGxxxxxP sequence motif suggest that many, but not all other trans-AT 
PKS harbor this extension (Figure S 7) (Table S 3 and Table S 4); it is observed in the trans-AT PKS 
RhiE but replaced by a loop in the trans-AT KS PksK (Figure S 2). The β-hairpin is neither 
approaching the catalytic center nor contributing to the dimer interface; its occurrence strictly in 
trans-AT PKS suggests a role in trans-AT specific transient interactions. 
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A conserved linker domain fold with a novel cap organization in Bb-KS2-LD 
Bb-KS2 is followed by a small domain comprising a three-stranded β-sheet flanked by 
three α-helices with a C-terminal extension that wraps around the KS domain and connects to 
the downstream DH (Figure 15A). This α/β domain resembles the linker domain that attaches AT 
to KS in cis-AT PKS (Figure 15B) and is thus also termed linker domain (Bb-LD). The crystal 
structures of trans-AT PKS ketosynthases PksK and RhiE also contain a linker domain, which 
connect in these cases the KS domain to a KR domain (PksK-LD) and to a B domain (RhiE-LD), 
respectively (Figure 15C and D). Comparison of Bb-LD to 99 trans-AT PKS ketosynthases 
demonstrates that 84 harbor LD of similar length (Figure S 8A). Six KS domains have an ACP 
domain inserted in LD and in nine KS domain the LD is absent (Figure S 8B) (Table S 3).  
 
 
 
Figure 15: Comparison of the linker domain from trans and cis-AT PKS. (A) Structure of the linker domain from B. brevis 
trans-AT PKS and the linker domain of of module 5 from the DEBS operon (PDB code 2HG4). KS, LD and AT domains are 
colored in orange, light grey and salmon respectively. The three α- helices of Bb-LS2-LD located at the equivalent position 
of the AT domain in DEBS module 5 are colored by different shade of grey and numbered. Amino acids colored in yellow 
form a hydrophobic pocket and amino acids in blue form interaction in the crystal structure. The C-terminal helix of the 
AT domain of DEBS-KS5-LD-AT overlaps to the Helix 3 of Bb-LD (dark red). (B) Classification and schematic representation 
of the linker domain from trans-AT PKS. Classification was based the alignment of 212 ketosynthases sequences and 
PSIPRED [110] was used for secondary structure prediction. Representative structures for class I (Bb-KS2-LD; α-helical 
triangle with a characteristic sequence motif), class III (RhiE-KS3-LD; β-sheet - short loop - Helix 3 motif) (PDB code 4KC5) 
and class IV (loop - Helix3 motif; OzmH-KS3-LD) (PDB code 4OPE) are available. A model for class II (α-helical triangle 
without sequence conservation) was modeled [111] based on BryB-KS2 protein sequence.  
 
Bb-LD (aa. 2864-2899), contains three -helices arranged in a triangular shape (Figure 
15A), where AT is attached to in cis-AT PKS (Figure 15A). This -helical triangle has a hydrophobic 
surface and in the middle presents a characteristic pocket lined with hydrophobic residues 
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(Figure 15A, Figure S 9B and C). This region makes main crystal contacts to the neighboring LD 
(Figure S 9A). Key residues in Bb-LD involved in crystal packing interactions are conserved in 25 
out of 90 trans-AT PKS including PksK-LD (Figure 15B and Figure S 9D), which constitutes one 
class of KS-LD found in trans-AT PKS. A second class of KS-LD (30 out of 90) is also predicted to 
harbor a helical triangle but does not contain characteristic sequence motifs found for class I. 
Instead of a helical triangle, the LD of RhiE (aa. 3593-3616) contains a small β-sheet 
followed by a loop and a single α-helix, that corresponds to Helix 3 of Bb-LD triangle (aa. 2887-
2899) (Figure 15B). Six out of 90 KS-LD belong to class III. In class IV of LD (15 of 90 proteins), 
represented by the LD of OzmH-KS3 (Figure 15B), only Helix 3 and a connecting loop of the helical 
triangle is present. The majority of the KS-LD protein can be classified into these four classes (76 
of 90). For 14 out of 90 LD domains we were not able to unambiguously assign a class. From 
secondary sequence prediction eleven of those remaining 14 LD are supposed be exclusively α-
helical in the helical triangle region, as class I and II, but the overall sequence length of the helical 
triangle is reduced by about ten amino acids and it is unclear if these proteins contain three very 
short or two longer helices (Figure 15B). OzmQ-KS-LD is the only linker domain among 236 linker 
sequences (Table S 3), which contains an insertion of 120 amino acids between β-sheet 3 and 
Helix 3, comprising a complex α-helix/β-sheet organization (PDB code 4OQJ). For the remaining 
two KS sequences, including the well-studied ketosynthase from module 4 of VirA [112], a LD 
domain with Helix 3 is present but the helical triangle region is reduced to a minimum; about 25-
30 residues shorter then for class I and II and ten amino acids shorter then LD class IV, probably 
due to a deletion of the β-sheet 3 preceding the helical triangle (Figure 15B and Figure S 9).  
In cis-AT PKS LD are structurally highly conserved [14-16] and probably constitute a single 
class. In contrast, KS-LD domains in trans-AT PKS show a higher variability in sequence and 
structure. We identified at least four different classes of KS-LD that are distributed to all trans-AT 
PKS clusters from Gram-positive and Gram-negative bacteria. A comprehensive characterization 
and classification of 236 KS proteins from 20 trans-AT PKS clusters are summarized in Table S 4. 
The analysis showed that Helix 3 is conserved throughout all LD from trans-AT PKS and about 50 
% of sequences contain a LxxxWxxG motif (Figure S 8). Helix 3 structurally overlaps to the C-
terminal -helix of AT in cis-AT PKS (aa. 864-878 in DEBS-AT3 and aa. 856-870 in DEBS-AT5) 
(Figure 15B) [14, 15]. LDs in cis-AT PKs are thought to bind and orient the AT domain and in 
addition interact with the acyl-carrier protein for efficient substrate loading [8, 14]. Whether 
docking sites for discrete ATs and Acyl-Carrier proteins exist for trans-AT PKS KSs is unknown. It is 
tempting to speculate that the conserved Helix 3 might comprise a common general recognition 
motif in trans-AT PKS, whereas other parts of LD are used for specific interactions. 
 
Trans-AT PKS enoyl reductases are FMN-dependent TIM-barrel proteins 
In trans-AT PKS, AT-ER fusion proteins are stand alone enzymes and central in the 
biosynthetic pathway as the AT domain loads substrates to all ACP of the PKS cluster and the ER 
is responsible for most reduction steps during polyketide biosynthesis. For the AT domain of AT-
ER proteins structural and functional characterization is available [30, 105, 113], whereas for ER 
domains we have only limited information. To understand the biological function of ER we have 
purified homologous ER domains from a series of AT-ER or AT-AT-ER (abbreviated as ATx-ER) 
proteins derived from different trans-AT PKS assembly lines. MlnA from the macrolactin cluster 
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of B. amyloliquefaciens consists of an AT (aa. 1-300) and an ER (aa. 301-768) domain (MlnA-ER) 
(Figure 16A and Figure S 10). The isolated ER domain MlnA-ER was crystalized in space group 
C2221 with two molecules per asymmetric unit. The structure was determined by molecular 
replacement using the structure of FabK [101] as a search model and a final structural model was 
refined to Rwork/Rfree of 24.5 %/26.3 %, respectively at 2.8 Å resolution (Table S 1).  
 
 
 
Figure 16: Overall structure of MlnA-ER and comparison to other enoyl reductases. (A) Sequence organization of MlnA 
(AT-ER) and C0ZGR0, the AT-AT-ER protein from the PKS cluster B. brevis. The AT domain, the ER domain and the linker 
in-between are colored in green, red and light brown, respectively. (B) Overall structure of MlnA dimer. Molecule A and B 
are colored in forest and green, and their substrate binding domains are in dark and light grey, respectively. The FMN is 
shown in yellow sphere representation. The N-terminal residue connecting to the AT-domain is shown as a ball. (C) 
Crystal structure of the enoyl reductase FabK (PDB code 2Z6I), colored as in (B). (D) Structure of MlnA: Domains 
homologous to Fabk are colored green, trans-AT ER specific Insertions 1 to 3 are colored in blue. 
 
 The MlnA-ER monomer comprises a (β/α)8 TIM-barrel fold (aa. 424-619 and 718-768) 
with a large α-helical substrate-binding domain (aa. 620-717) and binds one flavin 
mononucleotide (FMN) cofactor (Figure 16B). The two MlnA-ER molecules are highly similar to 
each other, with a root-mean-square deviation (rmsd) of 0.4 Å for all Cα atoms. The closest 
structural homologue of MlnA-ER is FabK (Figure 16C) with an rmsd of 1.8 Å over 300 matching 
Cα atoms and a sequence identity of 17 %. The two MlnA-ER monomers form a large dimer 
interface (Figure S 11), comprising 52 aa and interface area of 1860 Å2. The substrate binding 
sites are located about 17 Å apart from the dimer interface, shielded by several secondary 
structural elements. Dimerization arranges the exit of the active center between the TIM barrel 
and the substrate-binding domain in opposing direction to the general dimer interface. The 
attachment points of the linkers leading to the AT domain at Pro324 are about 25 Å apart from 
each other and do not fall in the close vicinity of the two-fold dimeric axes.  
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The FMN cofactor is tightly bound in the TIM barrel by several highly conserved residues 
(Figure S 12). The FMN phosphate interacts with four main chain amides (Gly554, Gly555, Gly576 
and Ser577) and the side chains of Ser577 and Ser723 in a general phosphate binding motif also 
observed in FabK and other FMN-containing TIM barrel oxidoreductases [114]. The isoalloxazine 
ring of FMN contacts Met348, His349, Ser429 and Gln580. His349 serves as an H-bond donor with 
its main chain amide to the N5 of the isoalloxazine ring and modulates the redox potential of the 
cofactor [115]. A loop (aa. 510-520: EADCGSNTEQ) close to the active site has week electron 
density and was not modeled.  The corresponding loop in FabK and 2-nitropropane dioxygenase 
contain a strictly conserved Histidine, proposed to be involved in proton shuttling [101, 116]. In 
trans-AT ER this histidine is only present in 50 % of the sequences (Figure S 13), pointing to a less 
important role in catalysis. 
 
Core fold extensions of MlnA-ER are conserved in trans-AT PKS and PUFA synthases 
 MlnA-ER is significantly larger than its closest homologue FabK, mainly due to three 
insertions (Figure 16D). The first and second insertions are at the outside of the TIM barrel and 
pack against each other. They are comprised of residues building two β-strands (Insertion 1: aa. 
441-456) and inserted between α-helix4 and β-sheet5 of the TIM barrel, and two α-helices 
(Insertion 2: residues 476-505) placed between α-helix7 and β-sheet8 (Figure 16D). The β-hairpin 
Insertion 1 is remarkably similar to the β-hairpin extension observed in Bb-KS2 (aa. 2725-2737, 
red in Figure 14). Both Insertions 1 and 2 are 25 Å apart from the active side of MlnA are 
presumably not involved in the enzymatic activity. Insertion 3 in MlnA-ER extends the substrate-
binding domain by two α-helices (aa. 658-692) (Figure 16). As Insertion 1 and 2, the extension of 
the lid domain is probably not required for general stabilization of the core fold or a productive 
active site conformation, as evidenced from its absence in FabK. All extensions are conserved in 
trans-AT ER with Insertion 1 and 3 are reduced in OzmM (Figure S 13). 
Phylogenetically, trans-AT PKS ER proteins build a distinct subclass to FabK and show a 
close relationship to PfaD proteins [117]. PfaD are standalone enoyl reductases of about 550 
amino acids, catalyzing all reduction steps in the biosynthesis of long-chain polyunsaturated fatty 
acids (PUFAs) [118]. This biosynthetic pathway involves a multidomain enzyme complex related 
to polyketide synthases [119-121] and is present in several species of sea bacteria and recently 
also discovered in some terrestrial organisms [122]. PfaD homologous harbor all three insertions 
present in trans-AT ER, and additionally contain an 80 aa long N-terminal domain of unknown 
function (Figure S 14) [117]. The conservation of the expansion segments in trans-acting ATx-ER 
proteins and PUFA ER suggests a conserved function, possibly the formation of interdomain or 
transient intermolecular protein interactions. 
 
ER domains contribute to the dimerization of trans-acting ATx-ER  proteins/Models of ATx-ER  
derived from SEC-MALS and SAXS experiments 
No three-dimensional crystallographic structure of an intact ATX-ER is available. We thus 
aimed to use size-exclusion chromatography coupled to multi angle light scattering (SEC-MALS) 
and Small-Angle X-ray Scattering (SAXS) [112, 123, 124] to determine the oligomeric state and 
obtain shape information, respectively.  
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 The structural analysis of isolated domains of ATX-ER indicated that AT is monomeric 
[30] and ER dimeric proteins. For SEC-MALS analysis we used the ATX-ER protein C0ZGR0 (Figure S 
1) from the single NRPS/PKS cluster of B. brevis. C0ZGR0 is the only protein in the cluster that 
shows similarity to AT and ER proteins and probably delivers substrates to all proteins in cluster. 
It consists of two AT and one ER protein (AT1-AT2-ER) (Figure 16) and shows a high similarity to 
MmpC from the Mupirocin [33, 125, 126] biosynthesis pathway: AT1 shows high similarity to 
proofreading AT domains [127], whereas AT2 clusters to malonyl-CoA specific loading enzymes 
[87, 127]. Unfortunately, full length C0ZGR0 protein could not be recombinantly expressed. Thus, 
we produced two overlapping didomain proteins: The first construct includes both AT domains 
and about half of the subsequent linker to ER (AT1-AT2; aa. 1-648). The second construct consists 
of AT2 and ER (AT2-ER; aa. 320-1100): AT1-AT2 is a monomeric protein (Figure S 16A) and AT2-ER 
protein is mainly dimeric (Figure S 16B), as well as MlnA-ER (Figure S 16C). This suggests that the 
ER domain builds the dimeric core of ATX-ER proteins, and monomeric AT is located at the 
exterior. 
 The SEC-MALS experiments give information about the oligomeric state of a protein, but 
do not provide insights into the relative domain arrangement and flexibility of AT and ER in ATx-
ER proteins. In ATX-ER proteins, the AT1 and AT2 are connected via short 10-15 aa linking 
sequences and the AT to ER [37] is significantly longer (20 to 40 residues) and shows an increased 
helical propensity (Figure S 15) [128], pointing to different flexibility of the linking region. 
As representative protein constructs for SAXS analysis we used AT1-AT2 from B. brevis and 
DfnA AT-ER from Difficidine [129, 130] biosynthesis cluster of Bacillus amyloliquefaciens (Figure 
17A and B). Guinier's plot of the SAXS data of the AT1-AT2 gave an Rg of 38.9 ± 1.5 Å (Table S 5), 
while calculation of the distance distribution function (P(r)) using GNOM yielded a maximum 
particle diameter of (Dmax) of 115 Å (Figure S 17A), in agreement with a monomeric protein. A 
Kratky analysis of AT1-AT2 shows a bell shaped curve (Figure S 17B), consistent with a globular 
particle where both AT domains have a preferred relative orientation and low flexibility. Ab initio 
modeling using DAMMIF [131] for 20 independent runs revealed a kidney shaped particle (Figure 
17D). 
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Figure 17: In solution small-angle X-ray scattering analysis of ATx-ER proteins.  (A) Constructs used for SAXS experiments. 
AT, ER, linker domains are colored, red, green, light brown, respectively. Experimental scattering curves of C0ZGR0 AT1-
AT2 (B) and DfnA AT-ER (C). (D) Ab initio envelope of AT1-AT2 (left, red) and DfnA AT-ER (right) calculated from DAMMIF. 
The center of the first AT domain is indicated with a red dot. From this center the maximal distance to the second AT is 
85 Å. The SAXS shape of AT-ER show a two-fold symmetry consistent with a central ER dimer (colored in green). The 
monomeric AT would be located at the outside of the central ER dimer. A radius of 85 Å around the center of AT in AT-ER 
indicates the potential boundary of the second AT domain in AT-AT-ER proteins. 
 
 For DfnA AT-ER, the determined Rg of 49.9 ± 0.2 Å and maximum particle diameter (Dmax) 
of 176 Å (Figure S 17C) is consistent with a dimeric protein. The Kratky analysis of AT-ER showed 
an increase in the high q-range (Figure 17B), suggesting a higher domain flexibility then AT1-AT2. 
An ab initio modeling with P2 symmetry using DAMMIF [131] revealed similar arch-like shapes 
for 20 independent runs (Figure 17D). The shape suggests, that the dimeric ER sits at the center 
of the arch, and the AT domain would be located at the outside of AT-ER arch (Figure 17D).  
The ab initio three-dimensional envelops of AT-AT and AT-ER can be combined to get 
insights into AT-AT-ER proteins. For AT1-AT2, the center of the first AT1 has a maximal distance to 
the second AT2 about 85 Å. The projection of 85 Å from the center of AT in AT-ER to the first AT1 
suggests an extended arch-like structure of AT1-AT2-ER with a total arch radius of approx. 120 Å 
(Figure 17D). 
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Conceptual model of trans-AT PKS assembly line 
Classical cis-AT PKS assembly lines are characterized by their multimodular architecture 
where all catalytic necessary domains are integrated in giant multienzymes. This is in contrast to 
trans-AT PKS, where AT and ER proteins are standalone proteins, that transiently attach to the 
PKS machinery [40]. Analysis of the structural organization and characterization of the functional 
interplay between the PKS multienzyme and trans-AT-ER proteins is thus essential to understand 
trans-AT PKS biosynthesis. 
Here, we report the crystal structure of ketosynthase Bb-KS2, which is the first 
representative of ketosynthase clade VIII, including a Met-Cys active site motif. The amino acid 
immediately preceding the active site cysteine is important for substrate specificity [132] and the 
Bb-KS2 structure helps to understand the factors dictating specificity and selectivity of KS 
domains, which can be used as a model for potential PKS engineering approaches. In addition to 
the catalytic thiolase domain, Bb-KS2 contains a linker domain LD, which is conserved throughout 
trans-AT PKS ketosynthases (Table S 4). Based on bioinformatical analysis we identified four LD 
classes, that differ significantly in sequence, sequence length and structure, with highly divergent 
LD surfaces (Figure 15). Common to all trans-AT PKS LD classes is Helix 3, that is central in the AT-
to-KS-interaction in cis-AT PKS, suggesting a similar role in trans-AT PKS. 
The structure of MlnA-ER from the macrolactin biosynthesis operon from Bacillus 
amyloliquefaciens revealed a TIM barrel fold with large characteristic extension, conserved 
throughout trans-AT PKS PUFA biosynthesis (Figure S 14). These Insertions do not contribute to 
the formation of the active site or substrate binding, suggesting a role in protein-protein 
interactions. Such interactions are indeed confirmed for PksE, a MlnA homolog of the Bacillaene 
biosynthesis cluster of B. subtilis, which colocalizes to a bimodular PKS megaenzyme, PksR, and 
other PKS [40].  
AT-ER proteins are arch-like molecules, with the dimeric ER at the center and AT flexible 
attached to it (Figure 17). This dimerization might be important for efficient interplay with the 
dimeric PKS megaenzymes.   
The trans-AT PKS operons of Chivosazol [133, 134] and Disorazol [133, 135] biosynthesis 
contain a single AT-ER. But an enoyl-reduction step appears to be unnecessary for their 
respective polyketide biosynthesis [133-135]. One might speculate that ER is only present in both 
biosynthetic pathways due to an important structural function. As stated above, in cis-AT PKS, KS, 
AT, DH, ER and KR domains are integrated in the giant PKS assembly line (Figure 18A) and existing 
structural and functional information can be combined in a PKS model: The overall PKS structure 
is homodimeric, with the ketosynthase and dehydratase domains comprising the dimer interface. 
The AT domain is associated to KS via the LD domain and both together form the condensing 
part. The ER domain together with DH and KR build the modifying part of a PKS module (Figure 
18A). The presented structural and biophysical information on KS and ER in combination with 
recent structural information on trans-AT PKS [100, 109, 136] suggest a hypothetical model for 
the architecture of a complete trans-AT PKS module: The multienzyme core is formed by the 
dimeric KS, with the LD domain facing to the outside (Figure 18B). A DH dimer sits on top of KS 
and is attached to KR. The acyl-transferase and enoyl reductase activities are provided in trans, 
by the dimeric AT-ER (Figure 18B). In analogy to cis-AT PKS, the AT domain might interact with 
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the LD of KS, and additionally, the extensions of ER may contribute to interaction to the 
multienzyme. Such a temporary association to the PKS assembly line would support efficient 
substrate loading and modification and avoid slowdown of PKS biosynthesis. This interaction 
must be highly dynamic, as the AT-domain of AT-ER has to load substrates to all ACPs of the PKS 
cluster.  
 
 
 
Figure 18: Model of cis- and trans-AT PKS organization.  (A) Structural model of a complete cis-AT PKS module (KS-AT-DH-
ER-KR-ACP) based on the similar domain organization to pFAS [8, 137]. The LD of the dimeric KS domain serves as docking 
station for AT domain. (B) Structural model of a complete trans-AT module (KS-AT-DH-KR-ACP) and the corresponding 
standalone trans-AT-ER protein. It may dock to the conserved LD domain of KS, in analogy to cis-AT PKS. The AT domain is 
covalently linked to the ER domain by a short linker (dark line) probably containing a α-helix (black tube). The trans-ER is 
dimeric and the positioning of AT is limited by length of the AT-to-ER linker and the large extension of ER may contribute 
to binding. AT, Acyltransferase; ACP, Acyl Carrier Protein; KS, Ketosynthase; LD, Linker; DH, Dehydratase; ER, 
Enoylreductase; KR, Ketoreductase. 
 
To test this experimentally, we examined the interaction of Bb-KS2 with AT1, AT2, AT1-AT2 
and AT2-ER from C0ZGR0 of the corresponding B. brevis PKS cluster (Figure S 1) using analytical 
ultracentrifugation (AUC), microscale thermophoresis (MST) and surface plasmon resonance 
(SPR). But we could not detect any high affinity interaction (KD < 40 µM). To test if additional 
domains are necessary for protein-protein interaction, we produced the complete module 2 from 
C0ZGQ5, including DHKR (KS2-DHKR) and examined binding to the different AT1-AT2-ER 
constructs. Additionally, KS-DH-KR and AT-ER protein constructs from the Difficidin and 
Macrolactin operons were produced and biophysical tested for interaction. But as well, we could 
not detect any interaction with KD < 40 µM in MST, SPR and AUC. Our experiments do not exclude 
possible transient interactions, as for most multi-domain protein constructs solubility was limited 
to 50-70 µM.  
In summary, the reported structural and functional analysis provides insights into the 
central enzymes of trans-AT PKS assembly lines. The developed extended classification of trans-
AT ketosynthases is the basis for further studies to rationalize LD function and the revealed 
dimeric architecture of ER with characteristic extensions, will guide further enzymatic and 
functional studies. While KR, KS, DH and AT domains of cis-AT and trans-AT PKS share similar 
folds and catalytic mechanisms, there are considerable structural variations in ER: cis-AT ER has a 
medium-chain dehydrogenase/reductase (MDR) fold and trans-AT ER belongs to the TIM barrel 
enzyme family. Interestingly, this is analogous to type I fatty acid synthases (FAS) [137, 138], 
where metazoan FAS ER and fungal FAS ER are member of the MDR and TIM barrel fold family, 
respectively. Furthermore, fungal FAS and trans-AT ER share a common evolutionary ancestor 
[117]. The Insertion 3 of trans-AT ER, is also found in fungal FAS and used for intersubunit 
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connections. Our findings broaden the scope of modular assembly lines, and create new 
opportunities for advanced combinatorial biosynthesis of novel polyketides. 
 
METHODS 
Cloning, Expression and purification of KS-LD and MlnA-ER  
Bb-KS2 (Uniprot ID: C0ZGQ5, aa. 2310-2940) and AT1-AT2 (Uniprot ID: C0ZGR0, aa. 1-648) 
and AT2-ER (Uniprot ID: C0ZGR0, aa. 320-1100) were PCR-amplified from Brevibacillus brevis 
NBRC 100599 genomic DNA. The enoyl reductase domain of MlnA (Uniprot ID: A7Z470, aa. 300-
768) was cloned from Bacillus amyloliquefaciens FZB42 (DSM 23117) [129, 139] genomic DNA. All 
constructs were cloned into the expression plasmid pNIC28-Bsa4 [140], where they are linked to 
a N-terminal hexa-Histag followed by a TEV-protease cleavage site. The proteins were 
overproduced in E. coli BL21(DE3) pRIL pL1SL2 [141].  
 After lysis of the cells in 50 mM Hepes/NaOH, 500 mM NaCl, pH 7.4, 40 mM imidazol 
with a sonicator and centrifugation, the proteins were purified by immobilized metal-affinity 
chromatography on a Ni-NTA column (elution with 250 mM imidazole), TEV digested [142], 
followed by a Ni-NTA column step. After concentrating the proteins were subjected to size-
exclusion chromatography in 20 mM Hepes/NaOH pH 7.4, 250 mM NaCl, 5 % Glycerol and 5 mM 
DTT on a Superdex S200 column (GE Healthcare). The protein-containing fractions were pooled 
and concentrated in Amicon Ultra units (Millipore). 
 
Protein crystallization and structure determination 
Bb-KS2 crystals grew in vapor-diffusion sitting drop setups at 20 °C at a protein 
concentration of 10 mg/ml using 0.1 M sodium malonate, pH 7, and 15% polyethylene glycol 
(PEG) 3350. Rod shaped crystal were flash frozen in liquid nitrogen using Perfluoropolyether Cryo 
Oil. MlnA-ER crystals were obtained at 20 °C by sitting-drop vapor diffusion in 15 % PEG3350, 0.2 
M sodium malonate, pH 7 and diffracting to 3.5 Å resolution. Dehydration of the crystals by 
gradually increasing the PEG3350 and ethylene glycol concentration to 30% and 20% (v/v) over 
2h, respectively, improved the diffraction to 2.8 Å resolution. Data were collected at beamlines 
X06SA and X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland and 
processed using XDS [143, 144]. Bb-KS2 crystals belong to space group C2 with unit cell 
parameters of a= 113.3 Å, b = 85.8 Å and c=89.3 Å, with one molecule in the asymmetric unit. 
Structure determination was performed by molecular replacement with KS structure of DEBS5 as 
search model (Protein Data Bank accession code 2HG4, [15]). The final model includes residues 
2318 to 2934. MlnA-ER crystals belong to space group C2221 with cell dimensions a = 83.2 Å, 
b = 104.7 Å, and c = 216.1 Å and contain two molecules per asymmetric unit. Structure 
determination was performed by molecular replacement with FabK ER structure as search model 
(Protein Data Bank accession code 2Z6I, [101]. The final model comprises residues 325 to 767, 
the first 23 residues of the expressed protein, which would connect the ER domain to the AT 
domain in the native protein are disordered. Model building and structure refinement were 
performed for both structures with Coot [145], PHENIX [146] and Buster-TNT [147] (Tab. S1).  
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SEC-MALS 
For size-exclusion chromatography coupled with multi-angle light scattering (SEC-
MALS) measurements, 20 µl or 100 µl samples of 1-4 mg/ml protein were applied to a GE 
Healthcare Superdex 200 5/150 GL SEC column equilibrated overnight in either 20 mM Hepes pH 
7.4, 250 mM NaCl, 0.5 mM TCEP, 5% glycerol or without glycerol at 5 °C, using an Agilent 1100 
series HPLC system. Light-scattering and differential refractive index measurements were made 
using Wyatt miniDawn TriStar detector and a Wyatt Optilab rRex detector, respectively. The 
inter-detector delay volumes, band broadening, and the light-scattering detector normalization, 
were calibrated according to the manufacturer’s protocol using a 2 mg/ml BSA solution 
(Thermo Pierce) run in the same buffer. The absolute refractive index of the buffer was measured 
using the refractive index detector. The data were collected and processed using the Wyatt Astra 
5 software. The molar mass was calculated from a global fit of the light scattering signals from 
three detectors at different angles, and the differential refractive index signal, using algorithms 
in the Astra 5 software. 
 
Small angle X-ray scattering 
Small angle X-ray scattering (SAXS) data were collected at the coherent SAXS beamline 
X12SA at the swiss light source in Villigen Switzerland. All samples were dialyzed into freshly 
prepared 20 mM Hepes/NaOH pH 7.4, 250 mM NaCl, 5 % Glycerol and 5 mM DTT, diluted to 
concentrations between 3-12 mg/ml and constantly centrifuged (13,000 xg, 8 °C) until 
measurement. Glass capillaries (1 mm inner diameter) were mounted to a temperature-
controlled holder (12 °C). Data acquisition was performed using a Pilatus 2M detector, a detector 
distance of 2.14 m and an energy of 12 keV. 10 individual capillary positions and different data 
collection strategies were conducted (Tab. S2). New capillaries were used for every protein 
concentration and sample. Frames with artefacts (e.g. caused by air bubbles) were identified 
using beamline software (SAXS_inspect2) and excluded from the buffer and protein data sets. 
Radial averages were calculated using beamline software and exported to individual ascii files, 
containing the scattering vector q, the intensities, and the intensity errors. The scattering vector 
ranged from 0.005 to 0.7 Å-1 and is defined as q = 4π/λsinθ, were θ is half the scattering angle. If 
not more than 30 % of DfnA scattering profiles of the same capillary position and scan repeat 
were rejected, DATAVER [148] was used for profile averaging. Buffer profiles were subtracted 
using DATOP [148]. Scaling factors and p-values of a students-t test were analyzed using 
DATMERGE [148] and DATCMP [148], respectively, and plotted as function of capillary position 
and scan repeat [148]. The last 60 % of the data sets indicated a significant increase in scaling 
factors and a drop in p-values and therefore were excluded from further processing due to 
radiation damage. All remaining profiles were merged using DATMERGE [148], if no capillary 
position dependent fluctuation in scaling factors was observed. Artificial low resolution points, 
caused by the beamstop and micro aggregate, were removed in PRIMUS [149]. The radius of 
gyration (Rg) and zero angle intensity (I(0)) was calculated from the Guinier approximation using 
AUTORG [148] and is consistent with the values determined via the atomic distance distribution 
p(r) using DATGNOM. Scattering profiles at different concentrations were only merged using 
DATMERGE [148], if a noise reduction at medium and high scattering vectors could be obtained. 
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Ab initio shapes were calculated with the program DAMMIF [131] assuming prolate 
anisometry and two fold symmetry for DfnA. Shapes with low normalized special discrepancy 
were selected using DAMSEL [150], aligned with DAMSUP [150], averaged and filtered with 
DAMAVER [150]. Shapes were visualized using Pymol [151]. 
 
Data deposition  
The atomic coordinates for Bb-KS2 and MlnA-ER have been deposited in the RCSB Protein 
Data Bank and are available under the accession code 4Z37 and 4Z38, respectively.  
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Table S 1: Data collection and refinement statistics of Bb-KS2-LD and MlnA-ER. Values in parentheses correspond to the 
highest resolution shell. Datasets were collected at beamline X06DA at the Swiss Light Source in Villigen (Switzerland).  
 
  Bb-KS2-LD MlnA-ER 
PDB accession number   
Data collection statistics   
Spacegroup C2 C2221 
Cell dimensions and angle a = 113.29 Å 
b = 85.80 Å 
c = 89.25Å 
β = 121.5° 
a = 83.17 Å 
b = 104.67 Å 
c = 216.10 Å 
Wavelength λ 1.00000 Å 1.00000 Å 
Resolution 42.9 to 2.0 Å 108.0 – 2.8 Å 
Reflections 146,525 (22,323), 155,632 (15,978) 
Unique reflections 48,935 (7,705) 23,587 (2,324) 
Completeness 98.7% (97.2%) 99.7% (99.0%) 
Multiplicity 3.0 (2.9) 6.6 (6.9) 
Rmeas 8.9% (79.3%) 7.4% (70.4%) 
CC1/2 99.8 (72.7) 99.9 (81.8) 
I/σI 11.9 (1.7) 18.9 (1.7) 
Wilson B-factor 38.0 Å2 80.0 Å2 
Mosaicity 
 
0.136° 0.218° 
Refinement statistics   
Rwork / Rfree 16.2% / 19.8% 24.6% / 26.3% 
Atoms 5,270 7,159 
 Macromolecules 4,844 6,984 
 Ligand  62 
 Solvent molecules 426 113 
Protein residues 607 876 
Mean isotropic B-factor    
 Macromolecules 46.0 Å2 120.6 Å2 
 Ligand  91.0 Å2 
 Solvent molecules 46.0 Å2 73.1 Å2 
R.m.s.d. bond length 0.005 Å 0.013 Å 
R.m.s.d. bond angle 0.91° 1.58° 
Ramachandran angles    
 Favored / portion 98.0% 96.0% 
 Allowed / portion 1.7% 4.0% 
 Outlier / portion 0.3% 0.0% 
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Table S 2: Classification of the KS domain according to the precursor specificity and the residues localized within 15Å 
around the reactive cysteine [136].   Amino acid numbering corresponds to Bb-KS2.Bb-KS2 belongs to the clade VIII 
receiving a β-hydroxyacyl precursor as substrate for decarboxylative condensation.  
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Table S 3: Classification and characteristics of ketosynthase from trans-AT PKS.  The table lists the trans-AT PKS from B. 
brevis cluster and nineteen other trans-AT PKS [37]. Uniprot codes are in parentheses. Inactive KS domains are indicated 
by an asterix. The clade of the KS domain has been determined according to the precursor and the motif of residues 
localized within 15Å around the catalytic cysteine [136]. Differences in the motif are written in small letter. The amino 
acid preceding the catalytic cysteine is mentioned, as it appears to affect the size of the catalytic pocket [105]. All KS 
domain harbors the catalytic triad [87] unless otherwise mentioned by the single letter code of the corresponding amino 
acid. Inactive KS domains present an amino acid modification for one of the two catalytic histidines. However, the EtnI-
KS4 annotated as inactive [37] harbors the catalytic triad Cys-His-His and the VirA-KS3 annotated as active [37] lacks the 
full KSNIGH motif. The presence of the motif of the β-sheet and the α-helix extensions observed in Bb-KS2 are indicated 
by a tick (✓). Variation in the motif are mentioned. All KS domains harbor a similar linker domain as Bb-KS2-LD unless 
otherwise mentioned. Nineteen linkers out of 236 present an inserted ACP [136] localized after the corresponding first α-
helix of the Bb-LD (aa. 2786-2803). Those ACPs lack the catalytic serine. KS domains of split module have linker shorter 
than 90 amino acids. ChiB-KS1, KirAVI-KS1 and KirAVI-KS2 are followed by an AT domain and present a linker similar to 
the KS-LD-AT-LD found in the cis-AT PKS DEBS. Certain linkers present a shorter linker connecting directly to the following 
domain. The linker annotated by a tick (✓) present at the same position as the docking domain of Bb-LD, similar residues 
involved in crystal contact. A, Adenylation domain, AL, Acyl-CoA Ligase, ACP, Acyl-Carrier Protein, B, Branching domain, C, 
Condensation domain, CY, Cyclisation, DH, Dehydratase, ECH, Enoyl-CoA Dehydratase, ER, Enoyl Reductase, F, 
Formylation, FeeH, FeeH-like domain, FkbH, FkbH-like domain, GNAT, Acetyl-loading AT of the GCN5-related N-acetyl 
transferase superfamily, KR, Ketoreductase, KS, Ketosynthase, MT, Methyltransferase, OMT, O-methyltransferase, OX, 
Oxydation domain, OXY,  oxygenase, PS, Pyran Synthase, TE, Thioesterase. 
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Table S 4: Trans-AT PKS sequences used for sequence alignment shown on the figures S6, S7, S8 and S9.    
 
Organism Pathway PKS Uniprot number 
Candidatus Endobugula 
sertula (Bugula neritina 
bacterial symbiont) 
Bryostatin BryA A2CLL5 
BryB A2CLL1 
BryC A2CLL2 
BryD A2CLL4 
BryX A2CLL3 
Bacillus amyloliquefaciens 
(strain FZB42) 
Difficidin DfnD A7Z6D8 
DfnE A7Z6D7 
DfnF A7Z6D6 
DfnG A7Z6D5 
DfnH A7Z6D4 
DfnI A7Z6D3 
DfnJ A7Z6D2 
Streptomyces atroolivaceus Leinamycin LnmI Q8GGP3 
LnmJ Q8GGP2 
Bacillus amyloliquefaciens 
(strain FZB42) 
Macrolactin MlnB A7Z471 
MlnC A7Z472 
MlnD A7Z473 
MlnE A7Z474 
MlnF A7Z475 
MlnG A7Z476 
Pseudomonas fluorescens Mupirocin MmpA Q8RL76 
MmpB Q8RL74 
MmpD Q8RL72 
Streptomyces albus Oxazolomycin OzmH B2WW42 
OzmJ B2WW43 
OzmK B2WW44 
OzmN B2WW47 
OzmQ B2WW50 
Bacillus subtilis (strain 168) Bacillaene PksK P40806 
PksL Q05470 
PksM P40872 
PksN O31782 
PksR O31784 
Burkholderia rhizoxinica Rhizoxin RhiA A1KQR6 
RhiB A1KQR7 
RhiC A1KQR8 
RhiD A1KQR9 
RhiE A1KQS1 
RhiF A1KQS2 
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Table S 5: Data collection and scattering-derived parameters for AT1AT2 (C0ZGR0) and AT-ER (DfnA).  All data were 
collected at the Swiss Light Source in Villigen (Switzerland). ‡Reported for X mg/ml 
 
 
 AT1-AT2 (C0ZGR0) AT-ER (DfnA) 
Data-collection parameters   
Beamline X12SA (SLS) X12SA (SLS) 
Wavelength (Å) 1.00000 1.00000 
Detector distance (m) 2.14 2.14 
q range (Å-1) 0.005-0.707 0.005-0.707 
Capillary diameter (mm)  0.1 0.1 
Scan lengths / step size (mm) 4.5 / 0.5 4.5 / 0.5 
Positions / acquisitions 10 / 1 10 / 10 
Scan repeats 20 8 
Exposure time (sec) 0.5 0.04 
Concentration (mg ml-1) 8 3 
Temperature (K) 285 285 
Structural Parameters   
I(0) (Å-1) [from P(r)] 21.44 ± 0.02 0.55 ± 0.01 
Rg (Å) [from P(r)] 37.62 ± 0.05 51.21 ± 0.14 
I(0) (Å-1) [from Guinier] 22.09 ± 0.04 0.55 ± 0.00 
Rg (Å) [from Guinier] 38.94 ± 1.47 49.90 ±0.17 
Dmax (Å) 115 176 
Porod volume estimate (Å3) 114,514 219,499  
Monomeric dry volume calculated from 
sequence (Å3) 
91,665 (incl. Tag) 102,916 
Software employed   
Primary data reduction Beamline software,  Beamline software 
Sorting for radiation damage In-house Software, 
DATCMP, DATMERGE 
In-house Software, DATCMP, DATMERGE 
Data processing DATOP, DATAVER, GROM, 
AUTORG, DATGNOM, 
DATPOROD 
DATOP, DATAVER, GROM, AUTORG, 
DATGNOM, DATPOROD 
Ab initio modelling DAMMIF DAMMIF 
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Figure S 1: Schematic view of the hybrid NRPS/PKS cluster from Brevibacillus brevis.  The crystallized KS domain (grey 
frame) belongs to the module 2 of the PKS C0ZGQ5. The UniProt accession number is given on the left. AT: 
Acyltransferase, ACP: Acyl Carrier Protein, KS, Ketosynthase, DH, Dehydratase, ER, Enoylreductase, KR: Ketoreductase, TE, 
Thioesterase, C, Condensation domain, A, Adenylation domain, MT, Methyltransferase domain. 
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Figure S 2: Comparison of core-fold extensions in thiolase fold-like enzymes. The PDB codes are indicated in parentheses. 
The external β-sheet shared by the trans-AT PKS Bb-KS2 and RhiE-KS3 are colored in red. The pFAS and hFAS miss the 
green α-helix observed in PKS, fFAS and KAS. The three α-helices of the cap domain of Bb-KS2 and the equivalent α-
helices of the others PKS, FAS and KAS are colored in different shade blue. The orange balls on DEBS-KS3 and OzmH-KS4 
indicate absence of defined structure. The bacterial KASIII and the chalcone synthase exhibited several unrelated 
extension additional to the α/β thiolase core fold. 
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Figure S 3: Active site and substrate binding pocket of Bb-KS2. (A) Catalytic triad Cys2496, His2631 and His2671 of Bb-
KS2. The electron density of the catalytic cysteine 2496 indicates oxidation to cysteine-S-dioxide. (B) Substrate binding 
pocket of the dimeric Bb-KS2.  The three helix A, B, C of the cap domain are colored in different shades of blue. The amino 
acid of the catalytic triad Cys-His-His and the bulky methionine 2495 are shown as sticks and annotated for one 
monomer. The position of the active site of the second KS monomer is pointed by a black arrow. The binding pocket 
(white surface) of both KS monomer are narrowed by the Helix B. (C) Binding pocket of the E. coli KASI (PDB code 1EK4). 
The catalytic cysteine 163 has been mutated to a serine to covalently irreversibly attach a C12 fatty acid in the binding 
pocket. One of the histidine of the catalytic triad is shown by a stick. (D) Binding pocket of Bb-KS2. The equivalent view of 
the binding pocket of E. coli KASI is shown for Bb-KS2 with the catalytic His2631 and Cys2496 annotated. The binding 
pocket of Bb-KS2 is larger and the bulky methionine 2495 preceding the catalytic cysteine is colored in magenta. 
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Figure S 4: Dimer interface of Bb-KS2. (A) Residues involved in the dimer interface. Residues of the dimer interface were 
defined by PISA [152] and are colored in yellow. The three α-helices A, B, C of the cap domain are colored in different 
shades of blue. (B) Salt bridges connecting the helix B of each monomer in Bb-KS2. The Lys2461 and Asp2458 from each 
monomer form a 2.9 Å salt bridge. Annotated helix A and helix B belongs to the same monomer. 
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Figure S 5: Interface of KS with the downstream domain.  (A) Structure of the KS-LD-B domain of the trans-AT PKS RhiE. 
The interface between the KS and the B domain is indicated by a black circle. The helix A and B from the KS dimeric 
interface are colored in cyan and blue respectively. (B) Close-up view of the KS-B domain interface in RhiE. A hydrophobic 
interface is created by the Tyr3102, Val3107, Pro3832 and Tyr3833 from the KS and B domain (sticks representation). The 
Lys3099 forms hydrogen bonds with the Glu3653 of the LD preceding the B domain while the Lys3110 interacts with the 
main chain of the B domain at the position of the amino acid Arg3857 and His3858. (C) Crystal structure of the Bb-KS2-LD. 
The circle indicates the equivalent position of the KS-B domain interface from RhiE. The helix A, B and C from KS dimeric 
interface are colored in cyan, blue and skyblue respectively. (D) Close-up view of the interface position from Bb-KS2-LD. 
Charged amino acids at the interface of the KS with the subsequent DH domain are annotated. The Lys 2372 and the 
Glu2376 belong the Helix C of the cap domain. 
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Figure S 6: Multiple sequence alignment of the short α-helical extension (aa. 2571-2577) from Bb-KS2 with KS from trans-
AT PKS.  (A) Position of the short α-helix (green) and the connected β-sheets (yellow) on Bb-KS2-LD dimer structure. (B) 
Sequence conservation around the α-helical extension from Bb-KS2. Sequences were aligned using CLUSTALW. The final 
figure was generated by Geneious [153]. Highly conserved residues are shown white in black boxes (>80% conservation). 
Residues with sequence conservation >60% are in grey boxes. The sequence alignment shows the conservation of the 
LxxAxxD motif (green frames) in the short α-helix localized at the vicinity of the N-terminus in Bb-KS2-LD structure. Amino 
acid numbering and position of the α-helix (green tube) and β-sheets (yellow arrow) are indicated for Bb-KS2.  
 
 
 
 
68 
 
Figure S 7: Multiple sequence alignment of the β-sheet extension (aa. 2725-2737) from Bb-KS2 with several trans-AT PKS. Position of β-sheet extension (red) and the connected β-sheet (yellow) on Bb-KS2-LD 
dimer structure. (B) Sequence alignment of the region of the β-sheet extension from Bb-KS2 with several trans-AT PKS. Sequences were aligned using CLUSTALW. The final figure was generated using 
Geneious[153]. Highly conserved residues are shown white in black boxes (>80% conservation). Residues with sequence conservation >60% are in grey boxes. The β-sheet extension of Bb-KS2 is indicated on top 
by red arrows. The PxxxxxGxxxxxP motif is shown in red frames and conserved in 20 out 100 sequences from trans-AT PKS. 
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Figure S 8: Sequence alignment of 
the linker domain from trans-AT 
PKS. (A) Sequences were aligned 
using CLUSTALW. The final figure 
was generated using Geneious 
[153]. Highly conserved residues 
are shown white in black boxes 
(>80% conservation). Residues with 
sequence conservation >60% are in 
grey boxes. Amino acid numbering 
and position of the α-helix 
(magenta tube) and β-sheet 
(yellow arrow) are indicated for Bb-
KS2 linker. The three α-helices of 
Bb-LD corresponding to the figure 4 
are annotated with their number. 
The conserved LxxxWxxG motif at 
the position of the third α-helix of 
Bb-LD triangle is shown in magenta 
frames. (B) Sequence alignment of 
trans-AT PKS harboring shorter 
linker domains. The inactive OzmH-
KS4 is directly linked to an active KS 
domain whereas the other linker 
domains are located at the C-
terminal end of split-module. (C) 
Position of the secondary structure 
on Bb-LD. α-helix and β-sheet are 
colored in purple and yellow 
respectively. The three α-helices of 
the potential docking site for trans-
AT are annotated by number. 
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Figure S 9: Crystal contacts at the 
docking domain of Bb-KS2 linker. 
(A) Structure of two Bb-KS2-linker 
proteins interacting at the docking 
domain in the crystal. (B) Docking 
domain of one protein with amino 
acid involved in the interaction. 
Amino acids colored in yellow form 
the hydrophobic pocket. Amino 
acids represented by blue sticks 
form interaction between the two 
proteins in the crystal structure. (C) 
Surface representation of Bb-LD 
(grey). Residues lining a 
hydrophobic pocket are shown in 
yellow. Amino acids in blue are 
involved in crystal contact  (D) 
Sequence alignment of the three α-
helical triangle region from the 
linker domain. Sequences were 
aligned using CLUSTALW. The final 
figure was generated using 
Geneious[153]. Amino acids are 
colored by polarity. Classes of the 
linker domains LD are indicated on 
the right. The 25 first linker domain 
present amino acid with similar 
polarities at the same position as 
Bb-KS2 linker and PksK-KS2 linker. 
In Bb-KS2-LD crystal structure, 
proteins interact at the docking 
domain with hydrogen bonds 
between the two proteins (amino 
acids labeled by blue squares). A 
hydrophobic pocket (amino acids 
labelled by yellow squares) is 
formed at the middle of the 
docking domain. α-Helix and β-
sheet are indicated by pink tubes 
and yellow arrows, respectively. 
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Figure S 10: Schematic view of the macrolactin cluster from B. amyloliquefaciens FZB42. Based on the chemical structure 
of Macrolactin the enoyl reductase domain of MlnA is supposed to act after second KS domain of MlnB. KS, Ketosynthase; 
AT, acyl-CoA transferase, KR, ketoreductase, ACP, acyl carrier protein, DH, dehydratase, KR, ketoreductase, ER, enoyl 
reductase, TE, thioesterase. 
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Figure S 11: Dimer Interface of MlnA.  (A) Overall structure of MlnA dimer. Molecule A and B are colored in forest and 
green, respectively. Extra protein sequences additional to the FabK structure are shown in gray, the dimer interface is 
colored in red. The FMN is shown in yellow sphere representation. (B) Side view of the dimer interface of one monomer 
MlnA shown in surface representation. (C) Electrostatic potential of one monomer MlnA, in the same view as in (B). 
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Figure S 12: Active site of MlnA.  All residues are displayed in stick mode with carbon atoms of the apoprotein in grey, 
carbon atoms of the FMN in yellow, nitrogen in blue, oxygen in red, and phosphorus in orange.  
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Figure S 13: Multiple sequence alignment of the AT-ER proteins from several species. Highly conserved residues are 
shown white in black boxes (>80% conservation). Residues with sequence conservation >60% are in grey boxes. 
Sequences of representative ER proteins were retrieved from the UniProt database [154] (http://uniprot.org) and aligned 
using CLUSTALW. The final figure was generated using Geneious [153]. Protein abbreviations and UniProt accession 
numbers are BaeE, B. amyloliquefaciens FZB42 (A7Z4Y0); C0ZGR0, B. brevis (C0ZGR0); ChiA., S. cellulosum So ce12 
(A9EWA3); DfnA, B. amyloliquefaciens FZB42 (A7Z6E3); DisD, S. cellulosum So ce12 (Q4U443); LnmG, Streptomyces sp 
(Q8GGP5); MlnA, B. amyloliquefaciens FZB42 (A7Z470); MmpC, P. fluorescens (Q8RL73); PksE, B. subtilis 168 (O34787). 
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Figure S 14: Multiple sequence alignment of the ER proteins from trans-AT and PUFA biosynthesis pathways. (Top) 
Sequence organization of trans-AT ER and PfaD ER protein sequences. Insertion 1,2,3 (Ins1, 2, 3) are colored in blue. The 
PUFA specific N-terminal extension (~80 aa) is shown in green. Highly conserved residues are shown white in black boxes 
(>80% conservation). (Bottom) Sequence Alignment Residues with sequence conservation >60% are in grey boxes. 
Sequences of representative ER proteins were retrieved from the UniProt database [154] (http://uniprot.org) and aligned 
using CLUSTALW. The final figure was generated using Geneious [153]. Protein abbreviations and UniProt accession 
numbers are BaeE, B. amyloliquefaciens FZB42 (A7Z4Y0); DfnA, B. amyloliquefaciens FZB42 (A7Z6E3); MlnA, B. 
amyloliquefaciens FZB42 (A7Z470); PfaD, Vibrio sp. NSP560 (FOX3C1); PfaD, Nostoc sp. (strain ATCC 29411/PCC 7524 
(K9QLB4); PfaD, Shewanella oneidensis (strain MR-1) (Q8EGK4). 
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Figure S 15: Multiple sequence alignment of the AT-to-ER linker from several species. Highly conserved residues are 
shown white in black boxes (>80% conservation). Residues with sequence conservation >60% are in grey boxes.  
Sequences of the AT-ER proteins were retrieved from the UniProt database [154] (http://uniprot.org) and aligned using 
CLUSTALW[155]. The final figure was generated using Geneious [153]. Protein abbreviations and UniProt accession 
numbers are BaeE, B. amyloliquefaciens FZB42 (A7Z4Y0); C0ZGR0, B. brevis (C0ZGR0); ChiA., S. cellulosum So ce12 
(A9EWA3); DfnA, B. amyloliquefaciens FZB42 (A7Z6E3); DisD, S. cellulosum So ce12 (Q4U443); LnmG, Streptomyces sp 
(Q8GGP5); MlnA, B. amyloliquefaciens FZB42 (A7Z470); MmpC, P. fluorescens (Q8RL73); PksE, B. subtilis 168 (O34787). 
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Figure S 16: Molecular weight determination using size-exclusion chromatography coupled to multi-angle light scattering 
(SEC-MALS). (A) SEC-MALS chromatogram of the AT1-AT2 protein from B. brevis. The N-terminal His and TEV tagged Bb-
AT1-AT2 has a molecular weight of 75.9 kDa. (B) SEC-MALLS chromatogram of AT2-ER from B. brevis (Bb-AT2-ER). The N-
terminal His and TEV tagged Bb-AT2-ER has molecular weight of 90.1 kDa (or 180.2kDa for a dimer. (C) SEC-MALLS 
chromatogram of the MlnA-ER protein from B. brevis. The N-terminal His and TEV-cleavage-site tagged MlnA-ER has 
molecular weight of 55.6 kDa (or 111.2 kDa for a dimer. 
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Figure S 17: Distance distribution (A, C) and Kratky analysis (B, D) of AT-AT and AT-ER didomain proteins. Distance 
distribution function derived of AT1-AT2 from C0ZGQ0 (A) and DfnA AT-ER (C) calculated with GNOM. Kratky plot of AT1-
AT2 from C0ZGQ0 (B) and DfnA AT-ER (D). 
  
 
 
 
 
79 
PART II 
 
EXPRESSION, PURIFICATION AND BIOPHYSICAL CHARACTERIZATION OF LIPIN, 
A KEY REGULATOR OF LIPID METABOLISM 
 
 
 
Solène  F. Martin, Timm Maier* 
 
Biozentrum, Universität Basel, Klingelbergstrasse 50/70, 4056 Basel (Switzerland) 
 
Correspondence should be addressed to T.M. (timm.maier@unibas.ch)  
E-mail addresses: solene.martin@unibas.ch  
 
Keywords  
Lipin, PAH1, phosphatidate phosphatase, diacylglycerol, lipid metabolism, protein expression, 
insect cells, protein purification.  
 
 
  
 
 
 
 
80 
STATEMENT OF MY OWN CONTRIBUTION 
 
I designed, performed and analysed all experiments mentioned, in discussion with other 
lab members. I studied the lipin domain organization using bioinformatics tool as presented in 
Results & Discussion and wrote the manuscript.  
 
  
 
 
 
 
81 
ABSTRACT 
 
 Lipins are key regulators of eukaryotic lipid metabolism with a unique dual function as 
phosphatidate phosphatase enzyme at the endoplasmic reticulum membrane and as 
transcriptional coactivator in the nucleus. Several functional and structural domains have been 
characterized for the mammalian lipin and the yeast homologue PAH1 but the three dimensional 
structure and the structural basis underlying its dual role have not been identified. We have 
selected candidate lipin homologues for large-scale production and structural studies based on 
sequence and homology analysis. Recombinant lipins have been screened for expression and 
purification from E.coli and insect cells. Here, we report the successful large-scale expression and 
purification of a recombinant variant of the Kluyveromyces lactis PAH1 defined by limited 
proteolysis.  We identify monomeric and oligomeric forms of PAH1, and analyse the impact of 
phosphorylation and oxidation on this protein construct.  
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INTRODUCTION 
Lipin is a bi-functionnal protein that acts as phosphatidate phosphatase (PAP) in the 
triacylglycerol biosynthesis pathway and as transcriptional coactivator of fatty acid oxidation 
genes [41]. 
  A single isoform of lipin is observed in yeast and nematodes whereas human and murine 
lipin occurs in three isoforms named lipin 1, 2 and 3 [48]. Lipin 1 has been identified initially after 
a spontaneous gene rearrangement in laboratory mice [78], which resulted in lipodystrophy, 
insulin resistance, peripheral neuropathy and neonatal fatty liver [9]. This phenotype, referred as 
fatty liver dystrophy (fld), can be caused by a single Gly84Arg mutation in the lipin gene [43]. In 
human, mutations in the lipin 1 gene have been associated with rhabdomyolysis, weakness and 
myoglobinuria; further polymorphisms in the gene are associated with body mass index and 
insulin sensitivity disorders [1]. Mutations in the human lipin 2 gene induce a different phenotype 
called Majeed syndrome, which is characterized by osteomyelitic lesions and dyserythropoeitic 
anemia [1].  Gene-expression revealed tissue-specific expression profiles of lipin isoforms [50]. 
Lipin 1 is broadly expressed but predominantly in muscle and adipose tissues. Lipin 2 and 3 have 
lower expression with lipin 2 localized into the brain, liver and gastrointestinal tract and lipin 3 
expressed at even lower level mainly in small intestine [1]. Different lipin isoforms within the 
same tissue can only partially compensate for each other [50].  
Lipins contribute to the balance between phosphatidate (PA) and diacylglycerol (DAG) by 
catalyzing via a DxDxT motif the dephoshorylation of PA to DAG in the triacylglycerol biosynthesis 
pathway [42]. PA and DAG serve as building blocks for triacylglycerol and glycerolipids and as 
signalling molecules in various pathways controlling cell growth, cell differentiation, insulin 
resistance and expression of genes linked to lipid metabolism [1]. In the nucleus, lipin 1 interacts 
via a LxxIL motif with the peroxisome proliferator-activated receptor α (PPARα) in complex with 
the PPARα coactivator 1α (PGC1α) in order to activate fatty acid oxidation genes [63, 65]. Lipin 1 
also activates PPARγ via a VxxLL binding motif [64] and a transcriptional activation domain (TAD) 
[64]. Other factors are regulated by lipin 1 such as the myocyte enhancer factor 2 (MEF2), the 
nuclear factor of activated T-cells c4 (NFATc4) and the sterol response element binding protein 1 
(SREBP1) [1].  
Lipin is regulated by several mechanisms including phosphorylation, sumoylation and 
protein-protein interaction. The yeast homologue PAH1 can be phosphorylated on multiple sites 
and by several kinases including Pho85p-Pho80p [66], Cdc28p-cyclin B [67], protein kinase A [68, 
69], protein kinase C and casein kinase II [69]. Hyperphosphorylated lipin associates in the cytosol 
via its Serine Rich Domain (SRD) with the 14-3-3 protein, which blocks its translocation to other 
cellular compartments [70]. Dephosphorylation of the yeast PAH1 is mediated by the 
transmembrane protein phosphatase complex Nem1p-Spo7p [72] and is required for the binding 
of lipin via a HRVF motif to the Ser/Thr protein phosphatase 1 catalytic unit γ (PP-1cγ) [73]. 
Binding of lipin 1 to PP-1cγ allows its translocation to the endoplasmic reticulum (ER) membrane 
and the nucleus. At the ER membrane, lipin 1 preferentially binds di-anionic PA via a Polybasic 
domain/Nuclear localization signal (PBD/NLS) and exert its PAP activity [57]. The PBD/NLS 
domain [57] and the sumoylation of two lysines [74] are required for the translocation of lipin 1 
to the nucleus where it acts a transcriptional coactivator. 
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Lipin is a key regulator in lipid homeostasis. Several functional domains have been 
associated with catalytic activity and different protein-protein interactions. However, the 
structure of lipin as a basis to understand the effect of mutations and polymorphisms inducing 
human diseases remains unknown. Production of stable and monodisperse lipins is a prerequisite 
for structural studies and has not been previously achieved. Lipins with shortest disordered 
regions were selected by bioinformatics analysis. Lipin constructs were screened for expression 
in E. coli and insect cells and short stable fragments were defined by limited proteolysis. Here, we 
report a protocol for large-scale expression and purification of the recombinant variant PAH1 
from Kluyveromyces lactis. We characterized the oligomeric states of PAH1 by size-exclusion 
chromatography coupled to multi-angle light scattering (SEC-MALS) and we determined the 
phosphorylation status and redox resistance property from initial biophysical studies.  
 
RESULTS & DISCUSSION 
Sequence-based definition of target sequences for lipin expression  
Sequence alignment and secondary structure prediction of lipin from different organisms 
reveal the presence of structurally conserved regions. Knowing the distribution of these regions 
is interesting to get an estimation of the region stability and the susceptibility for successful 
structural studies like x-ray crystallography, nuclear magnetic resonance (NMR), small-angle X-ray 
scattering (SAXS) and Electron Mycroscopy (EM). Three human lipin isoforms 1, 2, 3, three mouse 
isoforms 1, 2, 3, three fungal PAH1 and the Drosophila melanogaster lipin (Dm lipin) were studied 
by sequence alignment, Psipred [110] and Disopred [156]. Human lipin 1, 2, 3, mouse lipin 1, 2, 3 
and Saccharomyces cerevisiae PAH1 (ScPAH1) are 886 ± 38 amino acids long. Dm lipin is the 
longest with 1089 amino acids whereas Kluyveromyces lactis PAH1 (KlPAH1) and Chaetomium 
thermophilum (CtPAH1) have 796 and 748 amino acids respectively. Human lipin 1, 2, 3 are 
closely related with their respective mouse homologue 1, 2 and 3 (89%, 90% and 80% sequence 
identity respectively). Lipin isoform 1 shares 51% and 49% sequence identity with lipin 2 and 3 
respectively. The fungal PAH1 and the Dm lipin are more distant with only 29% and 35% 
sequence identity to the human lipin 1. Between the fungal PAH1, ScPAH1 has 50% sequence 
similarity with KlPAH1 and 37% with the CtPAH1 (Table S 1, Figure 19 and Figure S 18).  
All lipin present the N-terminal N-LIP domain (approximately 110 amino acids) and C-LIP 
domain (approximately 210 amino acids) localized at the C-terminus for human, mouse and Dm 
and centrally in the fungal PAH1 (Figure 19 and Figure S 18). Secondary structure prediction of 
the N-LIP reveals a well-structured domain with one N-terminal helix followed by six β-sheets. 
The C-LIP domain conserves the predicted α-helices/β-sheets architecture from fungi to human 
lipin (Figure 19). The N-terminal helix of the N-LIP corresponds to the amphipathic helix of  
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Figure 19: Characteristics of the mammalian lipin, Dm lipin and fungal PAH1 observed by sequence alignment and secondary structure prediction. Sequence alignment, secondary structures (purple α-helices 
and yellow β-sheets) and disordered regions (orange waves) gave information about the architecture of the lipin. The mammalian lipin refers to the human and mouse lipin isoforms 1, 2 and 3. The fungal PAH1 
refers to ScPAH1, KlPAH1 and CtPAH1. Motifs and domain followed by a question mark (KKRRKK PBD/NLS?, YxxLL?, Acidic Stretch?, LxxVL?) have been identified by sequence alignment but their functionality has 
not been studied. The sequence of acidic stretch for ScPAH1, KlPAH1, CtPAH1 and Dm lipin is written with aspartate and glutamate colored in red.  
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ScPAH1 (amino acids 1 to 18), which is required for membrane recruitment after 
dephosphorylation by Nem1p-Spo7p [59]. The lipin from human and mouse have similar N-
terminal sequence. However, mammalian lipin uses the PBD/NLS for PA binding. It is unknown if 
the N-terminal helix of mammalian lipin plays also a role in membrane recruitment. All lipins 
from fungi to human contains in their N-LIP, the HRVF motif for the binding of PP-1c, which is 
required for activation of the lipin, PAP activity and nuclear localization. All lipins also harbor the 
Gly84 of the mouse lipin 1 in a GEAxFV motif. Mutation of Gly to Arg is responsible for the fatty 
liver dystrophy phenotype in mice. The GEAxFV motif is conserved in 75 fungal PAH1 based on 
sequence alignment.  
The N-LIP of the human and mouse lipin isoforms is followed by a disordered region of 
approximately 350 amino acids. This region of lipin 1 contains three functional domains: 1) the 
PBD/NLS domain allowing either the binding of PA at the ER membrane or serving as nuclear 
localization signal, 2) the SRD domain for binding the 14-3-3 protein in the cytosol, 3) and the 
overlapping TAD for PPARγ activation in the nucleus. The PBD/NLS is present in all mammalian 
lipin isoforms. The SRD and TAD do not present high sequence similarity except for a PKSDSEL 
motif containing charged residues. This motif overlaps the SRD and the TAD but it has not been 
tested if this motif has functional relevance in 14-3-3 protein binding or PPARγ activation. A 90 
residues region following this disordered region does not have any identified functional domains 
but is structurally conserved by the presence of predicted α-helices and β-sheet. A second 30 to 
70 residues disordered region precedes the N-LIP.  
The intermediate region between the N-LIP and the C-LIP is different in the Dm Lipin and 
the fungal PAH1. The Dm Lipin present a longer intermediate region of 650 amino acids between 
the C-LIP and N-LIP compared to 470-510 amino acids in mammalian lipin isoforms. The 
intermediate region of Dm Lipin conserves the polybasic sequence KKRRKK, but for which the 
role of PBD/NLS has not been investigated, and conserves also the predicted α-helices/β-sheets 
containing region. In contrast, the intermediate region in fungi is much shorter with only 170 
amino acids for KlPAH1, 240 amino acids for ScPAH1 and 270 amino acids for CtPAH1. Fungal 
PAH1 lack the functional domains observed in mammalian lipins but they present the same 
architecture with the succession of disordered region/predicted α-helices/β-sheets 
region/disordered region.  
All lipins possess in the well-structured C-LIP the DxDxT motif for PAP activity. The 
mammalian and the Dm lipins present the LxxIL motifs for PPAR α binding. The fungal PAH1 have 
instead a LxxVL motif but it has not been investigated if this motif also interact with a fungal 
transcription factor. Modelisation of the human lipin 1 was tested with the Swiss Model [111]. 
Only very low quality models covering the amino acids 671 to 847 were generated. This region 
corresponds to the C-LIP and was built using templates from Haloacid dehalogenase-like 
hydrolase (PDB code 4eze) and deoxy-D-mannose-octulosonate 8-phosphate phosphatase (PDB 
code 1k1e). The region of the C-LIP seems to have a well-conserved architecture.  
The C-LIP is followed in the mammalian lipin by 60 amino acids sequence containing the 
VxxLL binding site for PPARγ. The Dm lipin presents at the same position a YxxLL motif, for which 
binding of PPARγ homologue has not been studied. In fungi the sequence following the C-LIP is 
more extended and represent 1/3 of the full length PAH1. The PAH1 C-terminus is mainly 
disordered. The 25 amino-terminal residues of ScPAH1 form an acidic tail, which is required for 
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binding and dephosphorylation of PAH1 by the Nem1p-Spo7p complex. Similar 
aspartate/glutamate-rich sequences are observed at the C-terminus of KlPAH1 and CtPAH1. 
Interestingly, the Dm lipin contains such acid stretch at its C-terminus but no insect phosphatase 
has been identified so far.  
 
Selection of fungal PAH1 for protein expression  
Protein Blast of ScPAH1 revealed more precisely the regions, which are functionally and 
structurally important (Figure S 19). Among 75 sequences of fungal PAH1 obtained from pBlast, 
all conserved the catalytic DxDxT motif and the glycine of the GEAxFV motif corresponding to the 
Gly84 of the fld mice (Figure 20). All fungal PAH1 harbor in the C-terminal a tail 
aspartate/glutamate-rich sequence, which is required for binding and dephosphorylation of 
ScPAH1 by the Nem1p-Spo7p complex (Figure S 20). Two PAH1 out of 75 do not have any 
sequence similarities for the N-terminal amphiphatic helix involved in membrane recruitment. 
Four fungal PAH1 do not have the HVRF motif for PP1cγ binding and four present a mutation to 
HIRF motif. PAH1 with short disordered region can be identified and selected for protein 
expression (Figure S 19). Among 75 fungal PAH1 sequence, four sequences are longer than 
ScPAH1 (862 aa). The other PAH1 are shorter up to 618 amino acids. The KlPAH1 (794 aa) and the 
CtPAH1 (747 aa) are good candidates for protein expression. KlPAH1 has the same length of C-
terminal disordered tail after the C-LIP than ScPAH1 but it has in general shorter internal 
disordered region between the N-LIP and the C-LIP (81 aa belonging to the disordered region) 
compared to ScPAH1 (143 aa belonging to the disordered region). Thermophilic fungi like 
Chaetomium thermophilum may produce protein thermostable. CtPAH1 has longer internal 
disordered region (163 aa between the N-LIP and C-LIP belongs to the disordered region) and 
shorter C-terminal tail (148 aa compared to 278 amino acid for ScPAH1).  
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Figure 20: Characteristics of the fungal PAH1 identified by sequence alignment of 75 PAH1 obtained from pBlast with ScPAH1. Sequence alignment, secondary structures (purple α-helices and yellow β-sheets) 
and disordered regions (orange waves) identified the well-known conserved domains (C-LIP and N-LIP in yellow) and highly conserved region in fungal PAH1 (light blue square).  
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Expression screening of eukaryotic lipins in E. coli 
So far, lipin has been recombinantly expressed for immunofluorescence microscopy, 
immunoblotting, immunoprecipitation and PAP activity assay but literature does not mention any 
large-scale purification of lipin with high purity and absence of degradation, as it is required for 
crystallization. E. coli is a well-established and fast sytem for protein expression and expression of 
lipin in such system has been reported [42]. E. coli was used as first strategy to express 
recombinant Lipin. A first trial of protein purification on a 5ml Ni-NTA column showed that the C-
term 6 His-tagged ScPAH1 and KlPAH1 did not bind to the column. The C-term His tag might not 
be accessible for binding to Ni-NTA material. A N-term tag has also been reported in literature for 
the lipin [51, 64] and was used as next strategy. Monitoring of the protein expression over time 
and a first step of protein purification on 5ml Ni-NTA column of the full length, the C-LIP and the 
N-LIP constructs of the ScPAH1 and hLPIN1 revealed that after lysis and fractionation, proteins 
remained mostly in the insoluble fraction (Table S 7). The full-length ScPAH1 and hLPIN1 showed 
C-terminal degradation judged from western blot against N-terminal His-tag. Both proteins were 
toxic for E. coli, the leaky pellet was an indication of cell lysis and cell density decreased overtime 
during protein expression. The shortened constructs of hLPIN1 and ScPAH1 did not affect 
bacterial growth but proteins remained mainly insoluble and the expression did not increase 
overtime even when E.coli density was quadrupling (Table S 7). On the overall, E. coli was not an 
appropriate expression system due to the toxicity, the insolubility and the low expression yields 
of the protein of interest. Expression of recombinant lipin has also been reported in insect cells 
[48] and was therefore used as second strategy for lipin expression. 
 
Expression screening of eukaryotic lipins in insect cells  
Gateway cloning technology was used to clone into pABG2-N-term-10His-Myc-Flag-TEV 
(HMF) tag-containing plasmid, several full-length lipin constructs from different organisms: 
human, mouse, Drosophila melanogaster, Saccharomyces cerevisiae, Kluyveromyces lactis and 
Chaetomium thermophilum. Lipin-containing pABG2 were transformed into DH10 EmbacY E. coli 
for baculovirus production. Positive bacmids controled by sequencing were transfected into 
insect cells Sf21 using Escort IV reagent (Sigma), to produce the initial virus V0. EmbacY bacmid 
contains an YFP gene to follow the infection by fluorescence microscopy of insect cells. V0 was 
amplified by successive infection of Sf21 cells, generating V1 for expression test and V2 as virus 
template for large protein production. 
Successful expression of lipin was challenged by the absence or very low expression of all 
lipin constructs observed at V1. Lipin-encoding-plasmid pABG2 and bacmids were cloned and 
sequenced again to overcome this problem. However, the critical point to observe protein 
expression was the V0 step. Initially, insect cells were transfected with EmbacY bacmid and 
Escort IV transfection reagent for four days and the supernatant V0 was used to generate V1 and 
to test the protein expression. In the modified protocol, cell medium was exchange after four 
days and infected cells were cultured for 3 more days. Insect cells fluorescence increased from 1 
to 50% from day 4 to day 7 and protein expression was positive after generating V1 based on 
anti-His western blot of cell lysis. Based on bioinformatics analysis and protein expression, 
KlPAH1 was used for purification test and optimization.  
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Strategy for the purification of recombinant lipin from insect cells 
A first strategy composed of three purification steps was designed for the full-length 
KlPAH1 construct: 1) affinity chromatography, 2) anion-exchange chromatography, 3) size-
exclusion chromatography. Affinity chromatography on nickel-charged resin retain successfully 
His-tagged KlPAH1 but required several steps of buffer optimization to get rid of the strongly 
bound contaminants. Full-length KlPAH1 was prone to degradation and C-terminal degradation 
fragments observed from western blot against N-terminal His-tag could not be eliminated from 
the three purification steps. Limited proteolysis was carried out to identify stable fragments. A 
527 amino acids fragment of KlPAH1 (Klarg: Methionine 1 to Arginine 527) was obtained by 
clostripain proteolytic digest and identified on SDS-PAGE followed by mass spectrometry analysis 
(Figure S 21). The cutting site of the Clostripain is localized 36 amino acids after the C-LIP domain. 
Klarg construct expressed without degradation fragments and in a good amount. From SDS-PAGE 
(Figure S 21), Klarg (61kDa) has a low electrophoretic mobility and runs at 73kDa. This 
electrophoretic behavior has been also described for the human lipin 1 [42]. 
Two purification strategies were tested for the Klarg construct: 1) affinity chromatography 
on Ni-NTA column followed by anion-exchange chromatography and gel filtration, or 2) affinity 
chromatography on a Ni-NTA column followed by tag-cleavage, orthogonal nickel-affinity 
chromatography and gel filtration. The SDS-PAGE of eluted fractions from gel filtration on 
Superdex 200 16/600 shows that both approaches yield protein at a purity above 95% (Figure 
21). Less contaminants are observed for untagged-Klarg from the strategy 2, due to high salt with 
(500mM NaCl) on the first step of Ni-NTA chromatography, which successfully removes various 
contaminants and was not applied for the strategy 1 performed previously (Figure S 22). A total 
amount of 10 mg of Klarg could be purified by each method from 25 g of cell pellet.  
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Figure 21: Last purification step of HMF-Klarg and untagged-Klarg on Superdex 200 16/600. Chromatogram and SDS-
PAGE of the elution of the HMF-Klarg (obtained from the strategy 1) (A) and the untagged-Klarg (obtained from the 
strategy 2) (B) show the purity of the protein and the presence of species with different molecular weights. Amount in ug 
of protein loaded on the gel is indicated for each elution fraction.  
Gel filtration on Superdex 200 16/600 revealed different oligomeric states of Klarg, 
which were further characterized by SEC-MALS. Two peaks at an elution volume of 47 and 67ml 
were observed for the HMF-Klarg (65kDa). The peak at 67ml was determined by MALS as the 
monomeric form of Klarg with a molecular weight of 68kDa, whereas the peak eluted at 47ml 
was identified as a complex mixture of species from 100 to 1000kDa (Figure 22). These peaks at 
47 and 67ml were run separately during SEC-MALS and identified as separate species, indicating 
that no monomer-oligomer equilibrium or a slow equilibrium occurs in solution. So far, 
monomeric form of lipin eluted from gel filtration has not been mentioned in scientific literature. 
One study mentioned the elution of mouse lipin 1 (monomere 98.6kDa) at 500-600kDa on a 
Superose 6 gel filtration [48]. This 500-600kDa species were defined by Liu et al. (2010) [48] as 
lipin oligomers rather than aggregates as the PAP activity is conserved suggesting that the 
proteins are functional.  
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Figure 22: Determination of the oligomeric state of Klarg by SEC-MALS. (A) SEC-MALS chromatogram of the GF elution 
peak at 47ml. The molecular weight corresponds to complex mixture of species from 100-1000KDa. (D) SEC-MALS 
chromatogram of the GF elution peak at 67ml. The Klarg species eluted at 67ml have a molecular weight of 68kDa 
corresponding to the monomeric form of Klarg (65kDa)  
 
The full length ScPAH1 expressed well and was tested for purification. Strategy 1 and 2 did 
not eliminate contaminants as well as for Klarg (Figure S 23). HMF-ScPAH1 (102kDa) also eluted 
in two peaks at 45.8 ml and 56ml from gel filtration (Figure S 23). The peak of elution at 56ml was 
identified by MALS as the mostly resolved monomer (100-130kDa) and the peak at 45.8ml was 
identified as oligomer/aggregate bigger than 1000kDa. Biophysical studies were pursued to 
determine if the oligomerization of Klarg and ScPAH1 was dependant of the redox condition from 
the buffer or the post-translational modifications such as phosphorylation.  
 
Biophysical characterization of eukaryotic lipins 
Sensitivity of Klarg oligomers to reducing agent was analysed by gel filtration on 
Superdex 200 5/150. Klarg oligomers eluted at 1.5ml whereas Klarg monomers eluted at 2.2ml. 
Addition of 25mM DTT to the Klarg oligomers showed an elution peak at 1.5ml, indicating that 
Klarg oligomers were redox-insensitive and did not involve formation of intermolecular disulfide 
bonds. Study from Liu et al. 2010 [48] also demonstrate the redox-insensitivity of lipin oligomers 
by coimmunoprecipitation of HA-tag lipin 1 and V5-lipin 1 in presence of DTT, NEM or H2O2.  
Post-translational modifications of Klarg and ScPAH1 were also analysed to determine if 
they play a role in protein oligomerisation. Phosphorylation sites of the monomeric and 
oligomeric forms of Klarg and ScPAH1 were identified by mass spectrometry. Four sites at the C-
terminus of ScPAH1 were significantly more phosphorylated on the monomeric form than on the 
oligomeric form (Figure S 25). However, Klarg does not contain this homologous portion and only 
one phosphorylation site was identified at the N-terminus on both monomeric and oligomeric 
form (Figure S 25). These results indicate that while oligomerization of ScPAH1 may depend on 
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phosphorylation, oligomerization of the Klarg lipin fragment does not. Co-immunoprecitation 
studies of HA-tag lipin 1 and V5-lipin 1 by Lui et al (2010) [48] shows similar behavior; co-
immunopreciation of these two species was not affected by the addition of lamda-phosphatase. 
Other modifications were identified on Klarg like the acylation of six lysines (50, 55, 179, 210, 
279, 289 and with a lower confidence 421) but with no difference between monomeric and 
oligomeric form. Oligomerization of Klarg is not influence by redox conditions and post-
translational modification. Isolation of the monomeric and oligomeric forms of Klarg and ScPAH1 
allow functional studies to determine whether they display equivalent enzymatic activities. 
Further biophysical studies were performed to determine a buffer composition appropriate for 
PAP activity assay.  
Thermofluor assay was used to determine a buffer suitable for protein stability, storage 
and analysis (Figure S 24). Klarg was equally stable in all tested salt conditions with melting 
temperature (Tm) varying from 37 to 40°C (Table 1). The pH has a greater influence on Klarg 
stability, decreasing pH from 8 (Tm 35°C) to 6.5 (Tm 45°C) increases Tm by 10°C. Similar behavior 
for ScPAH1 was observed with a minor effect of salt type and concentration but a considerable 
impact of pH (Table 1 and Figure S 24). ScPAH1 has a higher Tm of 5°C in general compared to 
Klarg. Sodium phosphate pH 6.5 has the highest Tm for both Klarg and ScPAH1 but phosphate 
ions are problematic for activity assay (Table 1). The activity assay is based on the quantification 
of free phosphate released by the phosphatase activity of the lipin. Based on the result of 
differential scanning fluorimetry screening the following buffer was chosen for all protein storage 
and analysis: 150mM NaCl, 2mM DTT in 100mM MES buffer at pH 6.5 (Table 1).  
 
Table 1: Melting temperatures of Klarg and ScPAH1 depending on buffer, pH and salt conditions.  Buffer conditions 
colored in orange have the highest Tm. MES: 2-(N-morpholino)ethanesulfonic acid, MOPS: 3-(N-
morpholino)propansulfonic acid 
 
 
 
Activity assays using colometric method were performed to determine if both monomeric 
and oligomeric species of Klarg and ScPAH1 have PAP activity. PAP activity was measured by 
following the release of free phosphate from the dephosphorylation of L-α-phosphatidic acid by 
Klarg ScPAH1
Buffer Sodium acetate pH 5 28.2 40.3
Sodium citrate pH 5.5 39.3 46.5
MES pH 6 43.4 46.3
BisTris pH 6.5 40.3 44.5
Sodium Phosphate pH 6.5 45.0 47.0
Imidazole pH 6.75 37.8 43.7
Potassium phosphate pH 7 42.5 45.8
Hepes pH 7 41.2 44.8
MOPS pH 7 39.6 44.3
Sodium Phosphate pH 7.5 38.8 43.5
Potassium phosphate pH 7.5 38.8 44.1
Hepes pH 7.5 37.9 42.9
Tris pH 7.5 37.5 42.7
Hepes pH 8 35.3 40.1
Tris pH 8.5 35.9 41.6
Bicine pH 9 33.7 38.8
Salt Ammonium chloride 37.0 42.2
Ammonium sulfate 40.5 46.2
Potassium chloride 38.4 42.8
Potassium acetate 40.0 45.0
Sodium chloride 38.9 43.3
Salt concentration 0 mM 38.0 42.8
125 mM 39.6 44.0
250 mM 39.3 43.9
375 mM 39.2 44.2
500 mM 37.6 43.3
Melting temperature (°C)
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PAH1. Reaction was stopped by addition of 0.1N HCl in methanol and free orthophosphates 
released by the PAP reaction were isolated from the hydrophobic L-α-phosphatidic acid using 
water/chloroform phase separation [42, 157]. In contact with malachite green molybdate 
reagent, free orthophosphate form a complex which absorbes at 620-640 nm [157]. PAP activity 
can be defined as the amount of enzyme that catalyzed the formation of one μmol of product per 
minute. So far, the enzymatic assay has been tested once but requires repetitive experiments to 
give confident results on Klarg and ScPAH1 PAP activity.  
 
Discussion 
Lipin is key regulator of lipid metabolism by its catalytic role in the triacylglycerol 
biosynthesis pathway and its transcriptional coactivator activity in lipid metabolism. Its role in 
lipid homeostasis is complex and highly regulated by several processes like phosphorylation, 
sumoylation and protein-protein interaction. Little is known about its structure, which would be 
of help to describe the protein-protein interaction interface and understand the effect of 
mutation involved in disease development. From bioinformatic analysis, we identify highly 
conserved domains, which seems to be important either for the structure, or the function of the 
lipin. The Gly84Arg responsible for the fld phenotype in mice is located in a GEAxF motif, which is 
conserved in all lipin from fungi to human. This mutation abrogates PAP activity [75] and blocks 
lipin-1 nuclear localization [43]. The gly84 is located 31 amino acids downstream the HRVF 
binding site for PP-1cγ. Mutation of this glycine may disrupt the structure of the N-LIP and the 
proper binding of PP-1cγ. The HRVF binding motif of PP-1cγ is conserved in mammalian lipin, Dm 
lipin and in 67 out of 75 PAH1 giving more evidence that PP1cγ binding is an important binding 
partner for the translocation of lipin to the ER membrane and the nucleus. It is interesting to see 
that the same domain PBD/NLS is used either for PA binding at the ER membrane or for 
translocation to the nucleus. A PKSDSEL motif overlaps the SRD and TAD domain in all 
mammalian lipins. The direct interaction of this motif to the 14-3-3 protein or to the PPARγ has 
not been investigated but a similar “ping-pong” binding mechanism can be hypothesized. This 
motif would serve either for 14-3-3 protein binding in the cytosol or activation of PPARγ in the 
nucleus. All lipin from fungi to human conserved a α-helices/β-sheets predicted region localised 
in the disordered part between the C-LIP and N-LIP. No function has been associated so far with 
this region but it seems to be important for the conservation of the structure of the protein. A 
tail enriched in aspartate/glutamate is present in all fungal PAH1. This acidic tail is required for 
the binding of Nem1p-Spo7p and the dephosphorylation of ScPAH1 [59]. The occurrence of the 
rich acidic sequence at the C-terminus of all fungal PAH1 indicates that this mechanism for PAH1 
dephosphorylation is well-conserved. No such stretch is observed in mammalian lipin and so far, 
no binding site for the CTDNEP1/NEP1-R1 mammalian homologue has been identified. 
Interestingly, the Dm lipin has a rich aspartate/glutamate sequence at its C-terminal suggesting 
that the enzyme, which dephosphorylates Dm lipin may use a similar binding site as observed in 
fungal PAH1. 
Given the importance of the structural and functional domains identified by sequence 
analysis, it is interesting to further explore their molecular interaction and function in the 3-
dimensional structure of the protein. We established a protocol for the expression and 
purification of the recombinant Klarg (KlPAH1 Met1-Arg527). We observed that insect cells Sf21 
 
 
 
 
94 
were more adapted for the expression of lipin compared to E. coli. We optimized the protocol of 
EmbacY bacmid infection to get increased protein expression. Protein of good purity could be 
obtained from three purification steps: 1) affinity chromatography on Ni-NTA column, 2) Ortho-
nickel chromatography, 3) and size exclusion chromatography. The full-length ScPAH1 was 
purified by the same protocol but various contaminants remained. From gel filtration and SEC-
MALS, we could identify that Klarg is purified in the form of two separate species, a monomere 
and an oligomer. There is no equilibrium between these two species. Similar behavior was 
observed for ScPAH1, which was purified as monomer and oligomeric species. The oligomer is 
not dependant of phosphorylation and acylation and is resistant to reducing agent. It has been 
shown by previous studies that the oligomer were able to dephosphorylation of PA, indicated 
that they are not aggregation of unfolded proteins. We started initial PAP activity assay but the 
several improvements are required before giving any conclusion concerning the activity of the 
purified Klarg and ScPAH1. X-ray crystallography studies are also of main interest to study the 
structure of ScPAH1 and Klarg. So far, no crystal hits could be observed from the first 
crystallization trial and buffer optimization is required to identify the nucleation conditions. The 
expression and purification of Klarg presented herein is the first protocol for high-scale 
production of recombinant lipin. It is the first step, which allows further structural and 
biochemical investigations on the lipin family. 
 
METHODS 
Bioinformatics  
Sequences were aligned using CLUSTALW and the final figure was generated by Geneious 
[153]. The secondary structure were predicted by Psipred [110] and the disordered region by 
Disopred [156].  
 
Cloning and protein expression in insect cells Sf21 
Lipin gene from Drosophila melanogaster (Uniprot Q8SXP0) and PAH1 from 
Saccharomyces cerevisiae (Uniprot P32567), Kluyveromyces lactis (Uniprot Q6CRD9) and 
Chaetomium thermophilum (Uniprot G0SF40) were PCR-amplified from genomic DNA of the 
corresponding organism. Lipin gene from human and mouse were purchased from ImaGenes 
GmbH and encode protein corresponding to the following Uniprot number: hLIPIN1α Q14693, 
hLPIN2 Q92539, hLPIN3 Q9BQK8, mLPIN1β Q80XT6, mLPIN2 Q99PI5, mLPIN3 Q99PI4. 
Recombinant baculoviruses were generated using the Bac-to-Bac baculovirus expression system 
(Invitrogen) according to the manufacturer’s protocol. Briefly, lipin genes were amplified by PCR 
using AttB site encoding primers. Gene of interested was transferred by BP reaction into 
pdonor221 and further LR reaction into pABG2 containing a N-terminal 10 Histidine-Myc-Flag tag 
followed by a TEV-protease cleavage site. Bacmid was generated from transformation of lipin-
encoded pABG2 into EmbacY E. coli. Plasmids and EmbacY bacmids were controlled by 
sequencing. In 6 wells plate, 2ml culture of Sf21 cells at 0.6 million cells/ml were transfected by 
lipin-encoded bacmid using Escort IV (Sigma) according to the manufacturer’s protocol to 
generate V0. Insect-XPRESSTM Protein-free Insect Cell Medium with L-glutamine  (Lonza) was 
used as growth medium and exchanged after 24 hours and 72 hours. At day 6, fluorescence of 
insect cells was observed under microscope to control transfection efficiency. Supernatant was 
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transferred to eppendorf tube and centrifuge for 5 minutes at 16000g. Supernatant 
corresponding to V0 was transferred to fresh tube and store in the dark at 4°C. Generation of V1 
and V2 were done according to Fitzgerald et al. [158]. Dilution of V2 to generate high scale 
culture was adapted according to V2 infection capacity. Sf21 Insect cells at 0.8 million cells/ml 
were infected by 1/400 (v/v) V2. After 24 hours, cells were diluted to 1 million cells/ml and 
completed with the addition of 1/400 (v/v) V2. Cells were harvested at 72hours with controlling 
the following parameters: fluorescence around 99% and viability between 80 and 95%. Cells were 
centrifuged at 1200g for 30 minutes at 8°C and pellet was stored at -80°C.  
 
Protein purification 
 Cell pellet were resuspended in lysis buffer (100 mM Hepes pH7, 150 mM NaCl, 30 mM 
imidazole, 7mM beta-mercaptoethanol) with addition of 4 μg/μl DNAse, a cocktail of protease 
inhibitor (PMSF, Bestatin, Pepstatin, Aprotinin, Phosphoamidon) and 33mM MgCl2. Cells were 
lysed using Microfluidizer®, centrifuged at 14200g, 45 min, at 4°C, and filter on 0.8um filter 
before loading on 5ml Ni-NTA column (Genscript). Contaminants were washed from the column 
by an extensive 20 CV column volume (CV) wash (100 mM Hepes pH7, 500 mM NaCl, 30 mM 
imidazole, 7mM beta-mercaptoethanol). Proteins were eluted with 500mM imidazole containing 
buffer. Proteins were TEV digested and dialysed overnight in dialysis buffer for ortho-nickel 
column (100 mM Hepes pH7, 150 mM NaCl, 7mM beta-mercaptoethanol). White turbidity was 
eliminated by filtering on 0.2μm filter before loading on ortho-Nickel column. Tag-cleaved 
protein were collected in the flowthrough and concentrating in Amicon Ultra units (Millipore) for 
size-exclusion chromatography. Proteins were eluted from Superdex200 16/600 (GE Healthcare) 
in gel filtration buffer (100mM MES pH6, 150mM NaCl, 2mM DTT) and concentrated in Amicon 
Ultra units (Millipore).  
 
Proteolysis digest 
Proti-AceTM 2 kit (Hampton Research) was used according to the manual. Subtilisin, α-
chymotrypsin, trypsin and elastase were purchased separately and added at the same 
concentration as the proteases in the kit. Samples were incubated overnight at 4°C before 
loading on SDS-PAGE for detection of proteolysis fragment. Identification of proteolysis fragment 
from SDS-PAGE bands was done by mass spectrometry in the Proteomics core facility of the 
Biozentrum.  
 
ThermoFluor Assay 
 ThermoFuor Assay was to test thermal stability of lipin in different buffer conditions by 
measuring its melting temperature ™. In 96-wells and optically clear plate, 2μl of protein (20uM) 
were added to 8μl SYPRO® Orange dye (5x final concentration) and 10μl of condition screen (1x 
final concentration). Condition screen test several buffers and pH (Sodium acetate pH5, Sodium 
citrate pH5.5, MES pH6, BisTris pH6.5, Sodium phosphate pH6.5, Imidazole pH6.75, Potassium 
phosphate pH7, Hepes pH7, MOPS pH7, Sodium phosphate pH7.5, Potassium phosphate pH7.5, 
Hepes pH7.5, Tris pH7.5, Hepes pH8, Tris pH8.5, Bicine pH9) in combination with salts 
(Ammonium chloride, Ammonium sulphate, Potassium chloride, Potassium acetate, Sodium 
chloride) at concentration from 0 to 500mM. Changes in fluorescence at 520nm du to binding of 
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SYPRO® Orange dye to unfolded protein was measured on C1000™ Thermalcycler (BioRad) 
coupled to CFX96™ Real Time System (BioRad). Temperature was increased from 4 to 90°C with 
0.5°C intervals every 40 secondes. The derivative of the fluorescence signal was plotted as 
function of temperature to identify Tm. Tm for each condition was determined () and an average 
for conditions containing the same buffer at same pH, the same salt or the same salt 
concentration was calculated (Table 1).  
 
Activity assays 
PAP activity was measured by following the release of water-soluble free phosphate 
from chloroform-soluble PA. L-α-phosphatidic acid (Avanti) was solubilized at a concentration of 
10mM into 100mM Triton X-100. The reaction mixture contained 50 mM Tris-maleate pH7, 0.5 
mM MgCl2, 10 mM β-mercaptoethanol, 0.2 mM L-α-phosphatidic acid (Avanti) in 2 mM Triton X-
100 and 0.5ng/μl enzyme in a total volume of 50μl. Enzyme was added to other tubes at 5 
minutes intervals. The reaction mixture was incubated at 37 °C and enzymatic reaction was 
stopped for all tubes at the time point 20 minutes by adding 250μl of 0.1N HCl in methanol. 
Phase separation was performed by adding 500μl of chloroform and 500μl of milli-Q water. 
Samples were shacked vigourously for one minute and centrifuge three minutes at 100g. After 
phase separation, 700μl of the aqueous (upper) phase was mixed with 100μl milli-Q water. 200ul 
of malachite green-molybdate reagent (MGM reagent, 2.64mM malachite green, 3.1mM H2SO4, 
60.7mM (NH4)6Mo7O24, 10% Tween) was added at one minute interval in to all tubes and mixed 
by inversion several times. Absorbance at 650 nm was measured at exactly 10 minutes after 
addiction of MGM reagent. The production of phosphate was quantified with a phosphate 
calibration curve. A unit of enzymatic activity was defined as the amount of enzyme that 
96atalysed the formation of 1 μmol of product/min 
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Table S 6: Sequence similarity between lipins based on sequence alignment.    
 
 
  
% sequence 
similarity
Human lipin 1 
(890 aa)
Mouse lipin 1 
(891 aa)
86
Human lipin 2 
(896 aa)
Mouse lipin 2 
(893 aa)
90
Human lipin 3 
(851 aa)
Mouse lipin 3 
(848 aa)
80
Human lipin 2 
(896 aa)
51
Human lipin 3 
(851 aa)
48
Dm lipin        
(1089 aa)
35
ScPAH1         
(862 aa)
28
KlPAH1         
(794 aa)
31
CtPAH1         
(747 aa)
27
KlPAH1         
(794 aa)
50
CtPAH1         
(747 aa)
38
Human lipin 1 
(890 aa)
ScPAH1          
(862 aa)
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Table S 7: Expression of recombinant lipin in E. coli.   
 
 
 
Bacterial growth Expression profiles
Monitoring of optical density at 590nm 
after IPTG induction of two E. coli cultures 
at 37°C for 5 hours and 17°C overnight.
Monitoring by western blot every hours of 
E.coli  culture at 37°C for 5 hours
Mostly insoluble
Presence of C-terminal degraded 
fragments
Mostly insoluble
Protein expression does not increase over 
time even though bacterial density triple
Mostly insoluble
Presence of C-terminal degraded 
fragments
Mostly insoluble
Protein expression does not increase over 
time even though bacterial density 
quadruple
Full length human Lipin 1
Decrease of bacterial density during cell 
culture
C-terminal human Lipin 1 
construct (Ser623-Ala890)
No effect on bacterial growth
C-terminal ScPAH1 construct 
(Ser340-Ser655)
No effect on bacterial growth
No bacterial growthFull lenght ScPAH1
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Figure S 18: Sequence alignment of hLPIN1, 2, 3 , mLPIN1, 2, 3, DmLPIN, KlPAH1, ScPAH1, CtPAH1.  Domains are indicated by numbers or by their full name. The structurally conserved region in 75 fungi PAH1 is 
indicated by a light blue square. Domains mentioned with the question mark presents residues ressembling to the motifs but for which the function has not been studied.   
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Figure S 19 : Sequence alignment of 75 sequences of fungal PAH1.  Domains are indicated by numbers or by their full name. The structurally conserved region of the disordered part in 75 fungi PAH1 is indicated 
by a light blue square. The length of the disordered region for ScPAH1, KlPAH1 and CtPAH1 are indicated by number of residues in green square.  
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Figure S 20: C-terminal tail of 75 fungal PAH1. All fungal PAH1 contains enriched region of Aspartate/Glutamate (colored in red) residues, which serves in ScPAH1 for Nem1p/Spo7p binding.  
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Figure S 21: Limited proteolysis of the full-length KlPAH1.  A shorter fragment of KlPAH1 at 73kDa is obtained by 
Clostripain proteolytic digest (3) and was characterized by mass spectrometry as a KlPAH1 fragment from methionine 1 to 
arginine 527 (Klarg). Klarg (61kDa) runs at 73kDa on SDS-PAGE. This low mobility on electrophoretic gel has been 
described for the human lipin 1 [42]. 
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Figure S 22: Elution of the small variant of KlPAH1 (Klarg, Met1-Arg 527) from Ni-NTA chromatography column.  Same 
volume of insect lysis expressing HMF-Klarg (65kDa) was loaded on two separate 5ml Ni-NTA columns. Wash with 
500mM NaCl helps to eliminate contaminants. L: Load, FT, Flowthrough, W: wash, E: Elution.  
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Figure S 23: Gel filtration of HMF-ScPAH1 and untagged-ScPAH1 on Superdex 200 16/600. Chromatogram and SDS-PAGE 
of the elution of the HMF-ScPAH1 (obtained from the strategy 1) (A) and the untagged-ScPAH1 (obtained from the 
strategy 2) (B) show the purity of the protein and the presence of species with different molecular weights. ScPAH1 was 
obtained with a lower purity compared to Klarg.  
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Figure S 24: Melting temperature of Klarg and ScPAH1 measure by thermofluorassay.  Buffer, pH and salt conditions used 
to test thermal stability of Klarg and ScPAH1 are indicated on the left. Melting temperature is representing in the form of 
scale bar from 10 to 50°C colored in blue for Klarg and red for ScPAH1. MES: 2-(N-morpholino)ethanesulfonic acid, 
MOPS: 3-(N-morpholino)propansulfonic acid.  
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Figure S 25: Sequence alignment and mapping of phosphosite on ScPAH1 and KlPAH1. The phosphorylation sites in Pah1p were identified by O’Hara et al. [159]. Phosphosites identified by mass spectrometry are 
indicated by square. Residues predominantly phosphorylated in the monomeric form of ScPAH1 compared to the oligomeric form are colored in green. Residues predominantly phosphorylated in ScPAH1 but 
with less confidence are in yellow. Residues phosphorylated in both monomeric and oligomeric form of ScPAH1 and KlPAH1 are in grey. The arginine 527 corresponding to the last residues of the Klarg construct 
is indicated.  
 
 
 
 
 
 
 
108 
CONCLUSION & OUTLOOK  
 
This thesis focuses on enzymes involved in polyketide and lipid biosynthesis. Polyketide 
synthases and eukaryotic lipins are of major interest in human health. Polyketide synthases are 
mainly from microbial origin and responsible for the synthesis of therapeutical compounds such 
as antibiotics, immunosuppressant and anti-tumoral drugs. Eukaryotic lipins are key regulator of 
lipin metabolism by their phosphatidate phosphatase activity and their transcriptional 
coactivator function. Mutations and polymorphisms in lipin gene are associated with metabolic 
and inflammatory disorders highlighting the important role of lipin in lipid metabolism 
homeostasis. 
 
Structural organization of trans-AT-ER in complex with trans-AT PKS 
 In the present work, the structure of the KS domain with its linker domain from the B. 
brevis trans-AT PKS was determined by X-ray crystallography. The KS domain presents the 
thiolase fold and the catalytic triad Cys-His-His characteristic of the KS domain from cis-AT PKS 
and FAS. Helical and β-strand extensions absent in FAS and observed in B. brevis KS structure 
might be involved in domain interaction in modular trans-AT PKS. Structural comparisons and 
sequence alignment of 236 KS domains with their C-terminal linker from various trans-AT PKS 
highlight the presence of a structurally conserved linker domain, which in cis-AT PKS, docks the 
AT domain. In trans-AT PKS, the interface of the LD for potential docking of AT, could be classified 
into 4 groups depending on their structural organization. B. brevis LD presents a helical triangle 
interface with a central hydrophobic groove and peripheral charged residues making contact 
with other KS-LD protein in the crystal. However, no interaction between B. brevis KS-LD and 
didomain constructs from the related trans-AT-AT-ER could be detected in our experimental 
conditions but protein solubility limited the measurements and therefore cannot exclude the 
possibility of transient interactions.  
Collaboration with the Dr. Roman Jakob brought information on the structural 
organization of trans-AT-ER protein. The crystal structure of the ER domain from the trans-AT-ER 
of the macrolactin cluster of Bacillus amyloquefaciens revealed the dimeric TIM-barrel structure 
with additional insertions, which might serve in modular trans-AT PKS assembly. SAXS and SEC-
MALS studies showed the monomeric behaviour of the AT1-AT2 construct from B. brevis trans-
AT1-AT2-ER while the trans-AT-ER from the difficidine cluster of Bacillus amyloliquefaciens 
dimerizes at the ER interface.  
From these findings, we suggest a model of organization of the trans-AT PKS. The AT 
domain of the dimeric trans-AT-ER may interact with trans-AT PKS complex at the LD interface in 
order to be positioned like in cis-AT PKS. Extensions of the dimeric trans-ER may also contribute 
to the positioning of the trans-ER and the assembly with the trans-AT PKS. This model of trans-AT 
PKS in complex with trans-AT-ER bring new knowledge for the engineering of novel trans-AT PKS 
and combinatorial biosynthesis of novel polyketides. Redesign of biosynthetic pathways is often 
limited by lack of understanding of the structure, dynamics and interplay between the enzymatic 
domains. The present model increases the ability to identify interaction interface, which are 
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important for trans-AT PKS assembly. Maintenance of the inter-domain boundary is crucial for 
the transfer of the growing polyketide between successive enzymatic domains. In the design of 
hybrid PKS, non-natural trans-AT having appropriate interaction interfaces could be used for 
delivery of specific substrate to trans-AT PKS. Protein in trans are therefore interesting for 
domain swapping but they can also be engineered more easily compared to domain from the 
non-split cis-AT PKS assembly line. Mutagenesis of the active site from trans-AT and trans-ER can 
be used to synthesize specific products without destabilizing the trans-AT PKS complex. 
Engineering the great machinery of trans-AT PKS can produce large libraries of chemically 
complex coumpounds. There is significant interest in developing synthetic strategies that could 
be used to improve the pharmacological properties of polyketide. Complete synthesis of 
polyketide remains challenging by chemistry and semi-synthesis strategies that rely on 
diversifying the structures are limited by the polyketide scaffolds. Combinatorial biosynthesis 
based on hybrid PKS opens the route for the discovery of structurally and functionally diversified 
drugs.   
 
Pure and stable eukaryotic lipins for biophysical and structural studies 
The present work reports the challenging expression and purification of stable and 
monodisperse recombinant lipin. Successful protein expression was obtained in insect cells Sf21 
after adapting the baculovirus infection protocol. A stable construct of the Kluyveromyces lactis 
PAH1 was identified by limited proteolysis. Buffers composition and purification strategy was set 
up to allow successful and reproducible purification of the Klarg construct. Protein of good purity 
was obtained by three purification steps composed of 1) affinity chromatography on Ni-NTA 
column, 2) orthogonal nickel-affinity chromatography, 3) and size-exclusion chromatography. 
These expression and purification protocols are great tools for the large-scale production of pure 
Klarg, and the starting point for biophysical and structural studies. 
The presence of two separate species of Klarg was identified by gel filtration and SEC-
MALS, one specie behaving as monomer and the other one as oligomer. The oligomeric form of 
Klarg was shown to be independent of phosphorylation state and resistant to reducing agent. 
Activity assays and crystallization trials were started but require optimization. The purity of the 
Klarg is optimal for other structural studies such as NMR, SAXS and EM and the purification 
protocols can be further adapted for lipins from other organisms.  
Identifying the structural organization of lipin is of main interest since its role in metabolic 
disorders has been clearly identified in human and fld mice. Variations in lipin 1 expression levels 
and gene polymorphisms are associated with insulin sensitivity, diabetes, hypertension and 
myogloburinemia while mutations in lipin 2 result in the development of an inflammatory 
disorder in human patients. The conservation of one or several isoforms, in species ranging from 
yeast to invertebrates, plants and mammalians settle the fundamental role of lipin in cellular 
metabolism. By its phosphatidate phosphatase activity and its function as transcriptional 
coactivator, lipin play a paradoxical role in the lipid synthesis at the ER membrane and the 
activation of fatty oxidation gene in the nucleus. Exploring the structure of lipin will reveal the 
architecture of the catalytic site and the interaction interface with other transcription factors 
(PPARγ and PGC1α-PPARα) and regulatory proteins (14-3-3 protein and PP-1cγ). It can be 
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imagined that, based on the structural information, therapeutical molecules can be designed to 
modulate or mimic lipin functions in order restore the balance of lipids in metabolic diseases.  
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